Dengue vaccine tetravalent(Takeda)

THE LANCET Infectious Diseases. Volume 26Number 1 柳叶刀传染病学 26卷 1期 https://www.thelancet.com/journals/laninf/issue/current EDITORIAL(社论) 1 Urgent need for infection prevention and control in prisons 监狱中感染预防和控制的迫切需求 The Lancet Infectious Diseases The Lancet Infectious Diseases Vol 26(1):p1 COMMENT（述评） 2 Now is the time to integrate serology into routine infectious disease surveillance 现在是时候将血清学纳入常规传染病监测了 Simon Cauchemez The Lancet Infectious Diseases Vol 26(1):p2 3 Reassessing sotrovimab's role in COVID-19: insights and implications 重新评估索托维单抗在新冠肺炎治疗中的作用：见解与启示 Daniele Focosi,Fabrizio Maggi The Lancet Infectious Diseases Vol 26(1):p3 4 Shaping opportunities for future clinical trials in tuberculosis 为未来结核病临床试验创造机会 Ivan Noreña,Beno Mbeya,Joanitah Nalunjogi,Ombeni Chimbe,Norbert Heinrich The Lancet Infectious Diseases Vol 26(1):p5 5 Diversifying antimalarial treatment for uncomplicated Plasmodium falciparum malaria in Uganda 乌干达针对无并发症恶性疟原虫疟疾的抗疟治疗多样化 Arjen M Dondorp The Lancet Infectious Diseases Vol 26(1):p6 6 A safe start for PfSPZ Vaccine, but efficacy in children remains elusive PfSPZ疫苗安全起步，但在儿童中的疗效仍难以捉摸 Nicholas Aderinto,Temitomi Jane Oyedele The Lancet Infectious Diseases Vol 26(1):p8 7 Rifasutenizol-based triple therapy for Helicobacter pylori infection 以利法苏替尼唑为基础的三联疗法治疗幽门螺杆菌感染 Jinnan Chen,Hong Lu The Lancet Infectious Diseases Vol 26(1):p9 8 The smallest faith 最渺小的信念 Steven A Pergam The Lancet Infectious Diseases Vol 26(1):p11 9 Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease 新冠肺炎长期症状临床试验的阴性结果：为异质性疾病选择预后指标 Lara Goxhaj,Lisa McCorkell,Femke van Rhijn-Brouwer,Letícia Soares,Julia Moore Vogel,Chloé de Canson The Lancet Infectious Diseases Vol 26(1):p13 10 Strengthening global preparedness and response to arboviral disease threats: a call to action 加强全球应对虫媒病毒疾病威胁的准备和响应：行动呼吁 WHO Global Arbovirus Initiative Technical Advisory Group 世界卫生组织全球虫媒病毒倡议技术咨询小组 The Lancet Infectious Diseases Vol 26(1):p15 11 Introducing our cover artist for 2026: Daria Lada 介绍我们2026年的封面艺术家：达里亚·拉达 Marco De Ambrogi The Lancet Infectious Diseases Vol 26(1):p17 Correspondence（读者来信） 12 Epidemiological and virological update on the emerging SARS-CoV-2 variant BA.3.2 新兴新冠病毒变异株BA.3.2的流行病学和病毒学最新情况 Lu Zhang,Nianzhen Chen,Amy Eichmann,Inga Nehlmeier,Anna-Sophie Moldenhauer,Metodi V Stankov,Christine Happle,Alexandra Dopfer-Jablonka,Georg M N Behrens,Markus Hoffmann,Stefan Pöhlmann The Lancet Infectious Diseases Vol 26(1):e1 13 Effects of LP.8.1-adapted mRNA vaccination on SARS-CoV-2 variant neutralisation Christine Happle,Markus Hoffmann,Metodi V Stankov,Inga Nehlmeier,Amy Eichmann,Torsten LP.8.1适应性mRNA疫苗接种对新冠病毒变异株中和作用的影响 Witte,Luis Manthey,Stefan Pöhlmann,Alexandra Dopfer-Jablonka,Georg M N Behrens The Lancet Infectious Diseases Vol 26(1):e3 14 Artificial intelligence and spillover prediction: aligning innovation with empirical reality in One Health surveillance 人工智能与溢出预测：在“同一健康”监测中使创新与经验现实保持一致 Nader Ebrahimi,Amir Ghaemi The Lancet Infectious Diseases Vol 26(1):e6 15 Artificial intelligence and spillover prediction: aligning innovation with empirical reality in One Health surveillance – Authors' reply 人工智能与溢出预测：在“同一健康”监测中使创新与经验现实保持一致——作者回复 Frank Aarestrup,Marion Koopmans The Lancet Infectious Diseases Vol 26(1):e7 16 Time to tackle vaccine–HLA associations with artificial intelligence 是时候用人工智能解决疫苗-人类白细胞抗原关联问题了 Alexander J Mentzer,George Davey Smith,Teresa Lambe,Julian C Knight,Mary Carrington The Lancet Infectious Diseases Vol 26(1):e8 Corrections（更正） 17 Correction to Lancet Infect Dis 2025; published online Oct 29. 《柳叶刀-传染病》2025年更正；在线发表于10月29日 https://doi.org/10.1016/S1473-3099(25)00466-9 The Lancet Infectious Diseases Vol 26(1):e9 18 Correction to Lancet Infect Dis 2025; published online Oct 27. 《柳叶刀-传染病》2025年更正；在线发表于10月27日 https://doi.org/10.1016/S1473-3099(25)00546-8 The Lancet Infectious Diseases Vol 26(1):e9 19 Correction to Lancet Infect Dis 2025; 25: 1084–96 《柳叶刀-传染病》2025年更正；25卷：1084-1096页 The Lancet Infectious Diseases Vol 26(1):e9 20 Correction to Lancet Infect Dis 2025; published online Nov 10. 《柳叶刀-传染病》2025年更正；在线发表于11月10日 https://doi.org/10.1016/S1473-3099(25)00550-X The Lancet Infectious Diseases Vol 26(1):e9 Newsdesk（新闻台） 21 Highlights of IDWeek 2025 2025年IDWeek亮点 Phoebe Hall The Lancet Infectious Diseases Vol 26(1):e10 22 WHO publishes update on global antibiotic resistance 世界卫生组织发布全球抗生素耐药性最新情况 Timothy Jesudason The Lancet Infectious Diseases Vol 26(1):e11 23 European Commission to fund new medicines for dengue 欧盟委员会资助登革热新药研发 Sanjeet Bagcchi The Lancet Infectious Diseases Vol 26(1):e12 24 Second report from the UK Covid-19 Inquiry 英国新冠肺炎调查第二次报告 Talha Burki The Lancet Infectious Diseases Vol 26(1):e13 25 Infectious disease surveillance update 传染病监测最新情况 Cahal McQuillan The Lancet Infectious Diseases Vol 26(1):e14 26 Research in brief 研究简讯 Priya Venkatesan The Lancet Infectious Diseases Vol 26(1):e15 Obituary（讣告） 27 Jean Louis Abdourahim Ndiaye 让·路易斯·阿卜杜拉希姆·恩迪亚耶 Sanjeet Bagcchi The Lancet Infectious Diseases Vol 26(1):p19 Profile（人物介绍） 28 Fortunate Machingura—tackling climate change and disease 福图纳特·马辛古拉——应对气候变化与疾病 Tony Kirby The Lancet Infectious Diseases Vol 26(1):p20 Media Watch（媒体观察） Book（书籍） 29 The social and political drivers behind pandemics 大流行背后的社会和政治驱动因素 Emma Louise Fabiani The Lancet Infectious Diseases Vol 26(1):p21 Articles（论著） 30 Dynamics of endemic virus re-emergence in children in the USA following the COVID-19 pandemic (2022–23): a prospective, multicentre, longitudinal, immunoepidemiological surveillance study 新冠肺炎疫情后美国儿童地方性病毒重新出现的动态（2022-23年）：一项前瞻性、多中心、纵向、免疫流行病学监测研究 Hai Nguyen-Tran,Sang Woo Park,Matthew R Vogt,Perdita Permaul,Alicen B Spaulding,Michelle L Hernandez,Jennifer A Bohl,Sucheta Godbole,Tracy J Ruckwardt,Peter W Krug,Daniel L Moss,Alexandrine Derrien-Colemyn,Ananda Chowdhury,Gabrielle Dziubla,Lu Wang,Mike Castro,Sandeep R Narpala,Elizabeth R Longtine,Amy R Henry,Teri-T B Ngo,Leonid Dzantiev,George B Sigal,C Jessica Metcalf,David W Kimberlin,Samuel R Dominguez,Abraham Mittelman,Adrian B McDermott,Leonid A Serebryannyy,Bryan Grenfell,Kevin Messacar,Daniel C Douek The Lancet Infectious Diseases Vol 26(1):p22 31 Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial 索托维单抗与常规治疗对住院新冠肺炎患者的疗效对比（RECOVERY）：一项随机、对照、开放标签、平台试验 RECOVERY Collaborative Group RECOVERY协作组 The Lancet Infectious Diseases Vol 26(1):p34 32 A 3-month clofazimine–rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial 含氯法齐明-利福喷丁的3个月方案与标准治疗方案治疗药物敏感性结核病的对比（Clo-Fast）：一项随机、开放标签、2c期临床试验 John Z Metcalfe,Isabelle R Weir,Kimberly K Scarsi,Alberto Mendoza-Ticona,Samuel Pierre,Luke Hall,Jorge Leon-Cruz,Elin M Svensson,Simon E Koele,Wadzanai Samaneka,Cecilia Kanyama,Maxwell Yohane,Neetal Nevrekar,Busisiwe Ntsalaze,Jean Bernard Marc,Melanie Goth,Gary Maartens,Richard Chaissonon behalf of the ACTG A5362 study team The Lancet Infectious Diseases Vol 26(1):p46 33 Global policy responses to antimicrobial resistance, 2021–22: a systematic governance analysis of 161 countries and territories 2021-22年全球应对抗菌药物耐药性的政策反应：对161个国家和地区进行的系统性治理分析 Jay Patel,Sahar Saeedi Moghaddam,Sruthi Ranganathan,Neil Vezeau,Emily O'Neill,Anne Harant,Michael Stolpe,Lothar H Wieler,Tim Eckmanns,Devi Sridhar The Lancet Infectious Diseases Vol 26(1):p55 34 Efficacies of artemether–lumefantrine, artesunate–amodiaquine, dihydroartemisinin–piperaquine, and artesunate–pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial 乌干达6个月至10岁儿童使用蒿甲醚-本芴醇、青蒿琥酯-阿莫地喹、双氢青蒿素-哌喹和青蒿琥酯-吡喃隆治疗无并发症恶性疟原虫疟疾的疗效：一项随机、开放标签、4期临床试验 Moses R Kamya,Joaniter I Nankabirwa,Chris Ebong,Victor Asua,Moses Kiggundu,Stephen Orena,Martin Okitwi,Stephen Tukwasibwe,Bosco Agaba,Daniel Kyabayinze,Jimmy Opigo,Damian Rutazana,Benjamin Binagwa,Edward Mugwanya,Shakira Babirye,Gloria Sebikaari,Patrick M Condo,Grace Appiah,Sam L Nsobya,Melissa D Conrad,Philip J Rosenthal,Leah F Moriarty,Adoke Yeka The Lancet Infectious Diseases Vol 26(1):p67 35 Safety, tolerability, and protective efficacy of a radiation-attenuated, whole sporozoite malaria vaccine in children in Gabon: a randomised, double-blind, placebo-controlled, phase 2 trial 加蓬儿童使用辐射减毒全孢子虫疟疾疫苗的安全性、耐受性和保护效力：一项随机、双盲、安慰剂对照、2期试验 Selidji T Agnandji,Jeroen Bok,Ayodele Alabi,Anita L Kabwende,Armel Mbouna,Juste Bie,Eleonne Moukiti,Albert Lalremruata,Meral Esen,Andrea Kreidenweiss,Natasha KC,B Kim Lee Sim,Thomas L Richie,L W Preston Church,Matthew B B McCall,Stephen L Hoffman,Peter G Kremsner,Benjamin Mordmüller The Lancet Infectious Diseases Vol 26(1):p79 36 Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in São Paulo, Brazil: a test-negative, case–control study TAK-003登革热疫苗在2024年圣保罗暴发期间对青少年的有效性：一项测试阴性病例对照研究 Otavio T Ranzani,Felippe Lazar Neto,Lisany Krug Mareto,Thiago Sanches Brumatti,Roberto Dias de Oliveira,Patricia Vieira da Silva,Edinéia Ribeiro dos Santos,Tatiana Lang D' Agostini,Regiane A Cardoso De Paula,Natalie E Dean,Albert I Ko,Derek A T Cummings,Jason R Andrews,Matt D T Hitchings,Julio Croda The Lancet Infectious Diseases Vol 26(1):p91 37 Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre, randomised, triple-dummy, double-blind, controlled, non-inferiority trial 以利法苏替尼唑为基础的三联疗法与铋剂加克拉霉素为基础的三联疗法作为中国幽门螺杆菌感染一线治疗的对比（EVEREST-HP）：一项3期、多中心、随机、三模拟、双盲、对照、非劣效性试验 Zhiqiang Song,Liya Zhou,Weihong Wang,Cheng Lan,Tongyu Tang,Jun Xie,Huizhen Fan,Xuehong Wang,Xiuli Zuo,Yin Zhu,Chengxia Liu,Yongsong Gu,Huang Feng,Xiang Gao,Qing Zhang,Hong Zhang,Jing Chen,Guozhu Geng,Zhenkun Maon behalf of the EVEREST-HP Study Group The Lancet Infectious Diseases Vol 26(1):p101 Series（专题研讨会） 38 Prevention and Management of Infections in People who are Immunocompromised 免疫功能低下人群感染的预防和治疗 Innovation in active and passive immunisation of people who are immunocompromised: a call to action 免疫功能低下人群主动和被动免疫接种的创新：行动呼吁 Joshua A Hill,Jim Boonyaratanakornkit,Malgorzata Mikulska,Benjamin W Teh,William O Hahn,Ghady Haidar,Catherine Liu,Deepali Kumar,Michael G Ison,Natasha Halasa The Lancet Infectious Diseases Vol 26(1):e16 39 Prevention and Management of Infections in People who are Immunocompromised 免疫功能低下人群感染的预防和治疗 Tackling antimicrobial resistance in people who are immunocompromised: leveraging diagnostic and antimicrobial stewardship 应对免疫功能低下人群的抗菌药物耐药性：利用诊断和抗菌药物管理 Catherine Liu,Emily A Rosen,Erica J Stohs,Hannah Imlay,Masayuki Nigo,Lee S Gottesdiener,Miranda So,Frank Tverdek,Sanjeet Dadwal,Carlota Gudiol,Michael J Satlin,Susan K Seo,Jason A Trubiano,Ritu Banerjee,Kimberly E Hanson,Lilian M Abbo The Lancet Infectious Diseases Vol 26(1):e30 Review（综述） 40 Unveiling the incidences and trends of alveolar echinococcosis in Europe: a systematic review from the KNOW-PATH project 揭示欧洲肺泡棘球蚴病的发病率和趋势：来自KNOW-PATH项目的系统综述 Adriano Casulli,Bernadette Abela,Daniele Petrone,Barbara Šoba,Balázs Dezsényi,Jacek Karamon,Laurence Millon,Urmas Saarma,Daniela Antolová,François Chappuis,Severin Gloor,Marcel Stoeckle,Beat Müllhaupt,Relja Beck,Heimo Lagler,Felix Lötsch,Herbert Auer,Marie-Pierre Hayette,Libuše Kolářová,Sniedze Laivacuma,Mindaugas Šarkūnas,Vitalijus Sokolovas,Audronė Marcinkutė,Karin Troell,Ansgar Deibel,Pikka Jokelainen,Małgorzata Sulima,Dagny Krankowska,Stillhard Roman,Gaëtan-Romain Joliat,Nermin Halkic,Solange Bresson-Hadni,Joanna Halina Bednarek,Andrzej Załęski,Małgorzata Paul,Sheraz Yaqub,Mogens Jensenius,Joke van der Giessen,Laura Nabarro,Peter Chiodini,Florent Demonmerot,Jenny Knapp,Beate Grüner,Peter Kern,Lynn Peters,Federica Santolamazza,Azzurra Santoro The Lancet Infectious Diseases Vol 26(1):e49 Personal View（个人观点） 41 Azithromycin mass drug administration: balancing survival benefits and risks in children 阿奇霉素大规模药物给药：平衡儿童生存益处与风险 Nubwa Medugu,Ian C Michelow,Claudette Poole,Stephen K Obaro The Lancet Infectious Diseases Vol 26(1):e62 Clinical Picture（临床影像） 42 Unexpected finding in a 17-year-old female undergoing screening colonoscopy 17岁女性接受筛查结肠镜检查时的意外发现 Ziheng Calvin Xu,Ethan Tan,Mayur Garg The Lancet Infectious Diseases Vol 26(1):e75 THE LANCET Infectious Diseases. Volume 26Number 2 柳叶刀传染病学 26卷 2期 https://www.thelancet.com/journals/laninf/issue/current EDITORIAL(社论) 1 Call for letters 征稿启事 The Lancet Infectious Diseases The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p111 Comment（述评） 2 Long COVID is here to stay—even in children 长期新冠症状将持续存在——即使在儿童中亦是如此 Danilo Buonsenso The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p112 3 Beyond ritonavir-boosted nirmatrelvir: the case for ensitrelvir in COVID-19 treatment 利托那韦强化版奈玛特韦之外的选择：恩赛特韦在新冠肺炎治疗中的应用 Ming Hong Choi,Ivan Fan Ngai Hung The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p113 4 A new monoclonal in the arMAMentarium against malaria 抗疟“武器库”中的新型单克隆抗体 Freia-Raphaella Lorenz,Matthew B B McCall The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p115 5 Household transmission of mpox in Africa: limited in adults but more prevalent in children 非洲猴痘家庭传播情况：在成人中传播有限，但在儿童中更为普遍 Oriol Mitjà,Michael Marks The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p117 6 The lasting lessons of mpox: infection, vaccination, and immune memory 猴痘带来的持久教训：感染、疫苗接种和免疫记忆 Raianna Fantin,Camila H Coelho The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p118 7 Xpert-Ultra for diagnosing asymptomatic tuberculosis Xpert-Ultra用于诊断无症状结核病 Xia Yu,Hairong Huang The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p120 8 The genomic surveillance gap: averting the antimicrobial resistance pandemic requires global equity and action 基因组监测的差距：避免抗菌药物耐药性大流行需要全球公平与行动 David M Aanensen,Iruka N Okeke,Pilar Donado-Godoy,Beverly Egyir,Ravikumar K Lingegowda,Sonia Siaon behalf of the NIHR Global Health Research Unit on Genomic Surveillance of AMR The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p122 Correspondence（读者来信） 9 Spillover in dengue trials 登革热试验中的溢出效应 Thomas A Smith,Samuel I Watson The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e77 10 Spillover in dengue trials – Author's reply 登革热试验中的溢出效应——作者回复 Fernando Abad-Franch The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e78 11 Updating the traditional voriconazole trough concentration range 传统的伏立康唑谷浓度范围更新 Rongqiang Liao,Xiaoyuan Zheng The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e79 12 Updating the traditional voriconazole trough concentration range – Authors' reply 传统的伏立康唑谷浓度范围更新——作者回复 Inderpaul Singh Sehgal,Ritesh Agarwal,Valliappan Muthu The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e80 13 Clinical course and neurological profile of Kyasanur Forest disease 基萨努尔森林病的临床病程和神经特征 Nitin Gupta,Tirlangi Praveen Kumar The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e82 Corrections（更正） 14 Correction to Lancet Infect Dis 2025; published online Oct 10. https://doi.org/10.1016/S1473-3099(25)00482-7 对《柳叶刀-传染病》2025年发表内容的更正；10月10日在线发表。https://doi.org/10.1016/S1473-3099(25)00482-7 The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e83 15 Correction to Lancet Infect Dis 2025; published online Dec 1. https://doi.org/10.1016/S1473-3099(25)00681-4 对《柳叶刀-传染病》2025年发表内容的更正；12月1日在线发表。https://doi.org/10.1016/S1473-3099(25)00681-4 The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e83 Newsdesk（新闻台） 16 Promising early data for sorfequiline 索氟维林早期数据令人鼓舞 Ed Holt The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e84 17 Highlights from ASTMH 2025 2025年美国热带医学与卫生学会年会亮点 Marco De Ambrogi The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e85 18 Brazil approves domestic single-shot dengue vaccine 巴西批准国产单剂登革热疫苗 Marcia Triunfol The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e86 19 CDC cuts to childhood vaccine recommendations 美国疾控中心削减儿童疫苗接种建议 Priya Venkatesan The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e87 20 WHO launches unified plan for coronaviruses 世界卫生组织启动冠状病毒统一计划 Talha Burki The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e88 21 Infectious disease surveillance update 传染病监测更新 Cahal McQuillan The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e89 22 Research in brief 研究简讯 Priya Venkatesan The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e90 Obituary（讣告） 23 Walter Dowdle 沃尔特·道德尔 Sanjeet Bagcchi The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p124 Profile（人物简介） 24 Katie Anders—improving global dengue control 凯蒂·安德斯——改善全球登革热防控 Tony Kirby The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p125 Media Watch（媒体观察） Film（电影） 25 Eliminating Guinea worm 根除麦地那龙线虫 Sanjeet Bagcchi The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p126 Articles（论著） 26 Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR): a retrospective cohort study 奥密克戎时代儿童与青少年长期新冠症状与SARS-CoV-2再感染的关联（RECOVER-EHR）：一项回顾性队列研究 Bingyu Zhang,Qiong Wu,Ravi Jhaveri,Ting Zhou,Michael J Becich,Yuriy Bisyuk,Frank Blanceró,Elizabeth A Chrischilles,Cynthia H Chuang,Lindsay G Cowell,Daniel Fort,Carol R Horowitz,Susan Kim,Nathalia Ladino,David M Liebovitz,Mei Liu,Abu S M Mosa,Hayden T Schwenk,Srinivasan Suresh,Bradley W Taylor,David A Williams,Jeffrey S Morris,Christopher B Forrest,Yong Chenon behalf of the RECOVER Consortium The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p127 27 Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial 口服恩赛特韦与口服利托那韦强化版奈玛特韦在新冠肺炎治疗中的抗病毒疗效（PLATCOV）：一项开放标签、2期、随机、对照、适应性试验 William H K Schilling,Podjanee Jittamala,Phrutsamon Wongnak,James A Watson,Simon Boyd,Viravarn Luvira,Tanaya Siripoon,Thundon Ngamprasertchai,Elizabeth M Batty,Ellen Beer,Shivani Singh,Tanatchakorn Asawasriworanan,Timothy Seers,Koukeo Phommasone,Terry John Evans,Varaporn Kruabkontho,Thatsanun Ngernseng,Jaruwan Tubprasert,Mohammad Yazid Abdad,Wanassanan Madmanee,Jindarat Kouhathong,Kanokon Suwannasin,Watcharee Pagornrat,Tianrat Piteekan,Borimas Hanboonkunupakarn,Kittiyod Poovorawan,Manus Potaporn,Attasit Srisubat,Bootsakorn Loharjun,Kesinee Chotivanich,Mallika Imwong,Sasithon Pukrittayakamee,Arjen M Dondorp,Nicholas P J Day,Watcharapong Piyaphanee,Weerapong Phumratanaprapin,Nicholas J Whiteon behalf of the PLATCOV Collaborative Group The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p139 28 Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial 头孢地尔与标准疗法治疗医院获得性和医疗保健相关性革兰氏阴性菌血流感染（GAME CHANGER试验）：一项开放标签、平行分组、随机试验 David L Paterson,Helmi Sulaiman,Po-Yu Liu,Mark D Chatfield,Mesut Yilmaz,Zeti Norfidiyati Salmuna,Mohd Zulfakar Mazlan,Siriluck Anunnatsiri,Rujipas Sirijatuphat,Darunee Chotiprasitsakul,David C Lye,Jyoti Somani,Shirin Kalimuddin,Abdullah T Aslan,Visanu Thamlikitkul,Yi-Tzu Lee,Ya-Sung Yang,Yi-Tsung Lin,Wan Nurliyana Wan Ramli,Chien-Hao Tseng,Sophia Archuleta,Yvonne Fu Zi Chan,Brian M Forde,Hugh Wright,Adam G Stewart,Kay A Ramsay,Weiping Ling,Vicki Rossi,Tiffany M Harris-Brown,Patrick N A Harrison behalf of the GAME CHANGER Trial Investigators The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p148 29 Efficacy and safety of ascending doses of orodispersible ivermectin co-administered with albendazole for Trichuris trichiura infections in preschool-aged children in Tanzania: a 坦桑尼亚学龄前儿童感染毛首鞭形线虫时，递增剂量口服分散片伊维菌素与阿苯达唑联合用药的疗效和安全性：一项单盲、随机、对照、剂量递增、2期试验 single-blind, randomised, controlled, dose-ranging, phase 2 trial Viviane P Sprecher,Annina Schnoz,Stefan Biendl,Halima S Hussein,Sarah O Najim,Mohammed N Ali,Ibrahim S Mohammed,Said M Ali,Jan Hattendorf,Jennifer Keiser The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p160 30 Human monoclonal antibody MAM01 for protection against malaria in adults in the USA: a first-in-human, phase 1, dose-escalation, double-blind, placebo-controlled, adaptive trial 人源单克隆抗体MAM01保护美国成年人免受疟疾侵害：一项首次人体、1期、剂量递增、双盲、安慰剂对照、适应性试验 Kirsten E Lyke,Andrea A Berry,Matthew B Laurens,Jennifer Winkler,Sudhaunshu Joshi,Abra Rachida Koudjra,Lauryn Butler,Peter F Billingsley,Tales Pascini,Asha Patil,B Kim Lee Sim,Grace Fitzgerald,Julie Riegel,Kayla Andrews,Micha Levi,Aparna B Anderson,Charles D Wells,Hong Liu,James Huleatt,R Scott Miller The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p170 31 Characterising household transmission dynamics of clade Ib mpox in Burundi: a prospective cohort study 布隆迪Ib分支猴痘家庭传播动力学特征：一项前瞻性队列研究 Raoul Kamadjeu,Ferdinand Nsengimana,Manassé Nimpagaritse,Edna Moturi,Eric Kezakarayagwa,Rose Nkiko,Jonas Ngendakumana,Rémy Nimubona,Liliane Nkengurutse,Hamady Ba,Dionis Nizigiyimana,Paul Ngwakum,Mame Selbee Diouf,France Bégin,Joseph Nyandwi,Douglas James Noble The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p182 32 Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study 比利时猴痘病毒感染或改良痘苗病毒安卡拉株疫苗接种的长期后果（MPX-COHORT和POQS-FU-PLUS）：一项为期24个月的前瞻性和回顾性队列研究 Christophe Van Dijck,Nicole Berens-Riha,Luca M Zaeck,Cécile Kremer,Jacob Verschueren,Jasmine Coppens,Fien Vanroye,Elisabeth Willems,Evi Bosman,Natalie De Cock,Bart Smekens,Leen Vandenhove,Odin Goovaerts,Anke Van Hul,Janne Wouters,Bart K M Jacobs,Stefanie Bracke,Matilde Hens,Isabel Brosius,Elise De Vos,Eugene Bangwen,Sarah Houben,Achilleas Tsoumanis,Pedro Henrique Lopes Ferreira Dantas,Jojanneke Rutgers,Amber Lipman,Koen Wijnans,Patrick Soentjens,Emmanuel Bottieau,Chris Kenyon,Johan van Griensven,Thijs Reyniers,Niels Horst,Kevin K Ariën,Marjan Van Esbroeck,Andrea Torneri,Koen Vercauteren,Wim Adriaensen,Rory D de Vries,Joachim Mariën,Laurens Liesenborghs The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p190 33 Long-term risk of tuberculosis among individuals with Xpert Ultra trace screening results in Uganda: a longitudinal follow-up study 乌干达Xpert Ultra微量筛查结果阳性个体患结核病的长期风险：一项纵向随访研究 Joowhan Sung,Mariam Nantale,Annet Nalutaaya,Patrick Biché,James Mukiibi,Joab Akampurira,Rogers Kiyonga,Francis Kayondo,Michael Mukiibi,Caitlin Visek,Caleb E Kamoga,David W Dowdy,Achilles Katamba,Emily A Kendall The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p203 Review（综述） 34 Invasive group A streptococcal infections: lessons learned from the 2022–23 upsurge 侵袭性A组链球菌感染：从2022-23年激增中吸取的教训 Alix Flamant,Alicia Demirjian,Theresa Lamagni,Julie Toubiana,Pierre R Smeesters,Jérémie F Cohen The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e91 35 A clinical practice guideline for tuberculous meningitis 结核性脑膜炎临床实践指南 Joseph Donovan,Fiona V Cresswell,Elizabeth W Tucker,Angharad G Davis,Ursula K Rohlwink,Julie Huynh,Regan Solomons,James A Seddon,Nathan C Bahr,Arjan van Laarhoven,Suzanne T Anderson,Sanjay K Jain,Felicia C Chow,Sophie Pattison,James E Scriven,Gabriela Singh,Rob E Aarnoutse,Jan-Willem C Alffenaar,Sofiati Dian,Abi Manesh,Robin Basu Roy,Varinder Singh,Ronald van Toorn,Caryn M Upton,Reinout van Crevel,Kelly E Dooley,Diana Gibb,David Meya,Robert J Wilkinson,Ewelina Rogozińska,Usha K Misra,Anthony Figaji,Guy E Thwaites The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e96 36 Towards shorter therapy for candidaemia: defining uncomplicated candidaemia in adults 缩短念珠菌血症疗程：界定成人非复杂性念珠菌血症 Ilana Reinhold,Susanne Picardi,Blasius Liss,Danila Seidel,Jannik Stemler,Philipp Koehler,Tamara Ruegamer,Rosanne Sprute,Oliver A Cornely The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e112 Personal View（个人观点） 37 A transformation in cholera surveillance 霍乱监测的变革 Amanda K Debes,Erin T Baumgartner,Kendra N Williams,David A Sack The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e124 Clinical Picture（临床图像） 38 Paediatric ocular toxocariasis with relentless progression despite negative metagenomic testing 尽管宏基因组检测呈阴性，但儿科眼弓蛔虫病仍持续进展 Diya Shah,Shiama Balendra,Harry Petrushkin,Anamika Patel The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e130 THE LANCET Infectious Diseases. Volume 26Number 3 柳叶刀传染病学 26卷 3期 https://www.thelancet.com/journals/laninf/issue/current EDITORIAL（社论） 1 Promises and challenges of AI in infectious diseases 人工智能在传染病领域的承诺与挑战 The Lancet Infectious Diseases The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p213 COMMENT（述评） 2 More real-world evidence for RSV vaccines in the global community 全球范围社区呼吸道合胞病毒（RSV）疫苗的更广泛的现实证据 Kristina L Bajema,Wesley H Self The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p214 3 Rapid diagnostic antigen tests for mpox and the need for decentralised testing—not quite there yet 猴痘快速诊断抗原检测及分散检测的必要性——尚待完善 Daniel Mukadi-Bamuleka,Kevin K Ariën The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p215 4 Solving the data bottleneck for artificial intelligence in infectious diseases 解决传染病人工智能领域的数据瓶颈问题 Cesar de la Fuente-Nunez The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p217 5 Artificial intelligence and One Health: potential for spillover prediction? 人工智能与“同一健康”理念：能否预测病原体外溢？ Marion Koopmans,Istvan Csabai,Daniel Remondini,Emma Snary,Frank Aarestrup The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p219 6 Artificial intelligence in the development of vaccines for infectious diseases 人工智能在传染病疫苗研发中的应用 Steve Black,Shabir A Madhi,Rino Rappuoli The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p221 7 Peer review at The Lancet Infectious Diseases in 2025 2025年《柳叶刀-传染病学》期刊专家评审 Ursula Hofer The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p223 8 Thank you to The Lancet Infectious Diseases statistical and peer reviewers in 2025 感谢2025年《柳叶刀-传染病学》期刊的统计学及评审专家 The Lancet Infectious Diseases Editors The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e132 CORRESPONDENCE（读者来信） 9 Methodological considerations in the attribution of long COVID to first or second infection 首次或二次感染导致长期新冠症状的方法学考量 Sara Carazo,Danuta M Skowronski,Manale Ouakki,Gaston De Serres The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e139 10 Methodological considerations in the attribution of long COVID to first or second infection – Authors' reply 首次或二次感染导致长期新冠症状的方法学考量——作者回复 Bingyu Zhang,Qiong Wu,Ravi Jhaveri,Christopher B Forrest,Yong Chen The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e141 11 Humoral immunity after LP.8.1 monovalent vaccines against a broad range of SARS-CoV-2 variants including XEC, LP.8.1, NB.1.8.1, XFG, and BA.3.2 LP.8.1单价疫苗针对包括XEC、LP.8.1、NB.1.8.1、XFG和BA.3.2在内的多种SARS-CoV-2变异株的体液免疫应答 Yu Kaku,Mizuka Fujiwara,Keiya Uriu,Maximilian Stanley Yo,Shusuke Kawakubo,Jumpei Ito,Naoya Itoh,Yoshifumi Uwamino,Fumitake Saito,Hironori Satoh,The Genotype to Phenotype Japan (G2P-Japan) Consortium,Kei Sato The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e142 12 Precision diagnostics for MBLs: the true game changer in treating antimicrobial resistance 金属β-内酰胺酶精准诊断：治疗抗菌药物耐药性的真正变革者 Brenda A Warecki,María F Mojica,Alejandro J Vila,Robert A Bonomo The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e144 13 Precision diagnostics for MBLs: the true game changer in treating antimicrobial resistance – Authors' reply 金属β-内酰胺酶精准诊断：治疗抗菌药物耐药性的真正变革者——作者回复 David L Paterson,Abdullah T Aslan,Patrick N A Harris The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e145 CORRECTIONS（更正） 14 Correction to Lancet Infect Dis 2025; published online Dec 9. https://doi.org/10.1016/S1473-3099(25)00659-0 《柳叶刀-传染病学》2025年发表文章勘误；在线发表于12月9日。https://doi.org/10.1016/S1473-3099(25)00659-0 The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e146 15 Correction to Lancet Infectious Diseases 2026; published online Jan 20. https://doi.org/10.1016/S1473-3099(25)00773-X 《柳叶刀-传染病学》2026年发表文章勘误；在线发表于1月20日。https://doi.org/10.1016/S1473-3099(25)00773-X The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e146 NEWSDESK（新闻台） 16 Rabies an increasing threat in Ukraine 乌克兰狂犬病威胁日益加剧 Ed Holt The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e147 17 People needing trachoma interventions at record low 需要沙眼干预措施的人数创历史新低 Timothy Jesudason The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e148 18 Uneven STI response in EU/EEA countries 欧盟/欧洲经济区国家性传播感染应对措施不均衡 Sanjeet Bagcchi The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e149 19 Controversial HBV vaccine trial in Guinea-Bissau halted 几内亚比绍有争议的乙型肝炎病毒疫苗试验被叫停 Talha Burki The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e150 20 Research in brief 研究简讯 Priya Venkatesan The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e151 OBITUARY（讣告） 21 Ivan Hirsch 伊万·赫希 Sanjeet Bagcchi The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p224 PROFILE（人物介绍） 22 Reem Abu Shomar— championing water safety in Gaza 里姆·阿布·舒马尔——加沙地带水安全倡导者 Tony Kirby The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p225 MEDIA WATCH（媒体观察） Book（书籍） 23 A prescription for public health literacy 提升公众健康素养的良方 Vijay Shankar Balakrishnan The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p226 Book（书籍） 24 Imagining the inevitable 想象不可避免之事 Cahal McQuillan The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p227 Film（电影） 25 Women's autonomy, safe sex and HIV prevention 女性自主权、安全性行为与艾滋病预防 Sanjeet Bagcchi The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p228 ARTICLES（论著） 26 Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75–79 years in England: a multicentre, test-negative, case–control study 英国75-79岁成年人中双价呼吸道合胞病毒（RSV）预融合F蛋白疫苗对RSV相关住院的有效性：一项多中心、检测阴性、病例对照研究 Rebecca Symes,Heather J Whitaker,Shazaad Ahmad,David Arnold,Suryabrata Banerjee,Cariad M Evans,Robin Gore,Jennifer Hart,Katy Heaney,Onn Min Kon,Anne Melhuish,Munira Ortale Zogaib,Emanuela Pelosi,Najib M Rahman,Gerrit Woltmann,Tricia McKeever,Maria Zambon,Conall H Watson,Wei Shen Lim,Jamie Lopez Bernalon behalf of the HARISS network collaborators The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p229 27 Oral itraconazole versus oral voriconazole for treatment-naive patients with chronic pulmonary aspergillosis in India (VICTOR-CPA trial): a single-centre, open-label, randomised, controlled, superiority trial 印度治疗初治慢性肺曲霉病患者口服伊曲康唑与口服伏立康唑的对比研究（VICTOR-CPA试验）：一项单中心、开放标签、随机、对照、优效性试验 Inderpaul Singh Sehgal,Ritesh Agarwal,Sahajal Dhooria,Kuruswamy Thurai Prasad,Valliappan Muthu,Ashutosh Nath Aggarwal,Shivaprakash M Rudramurthy,Mandeep Garg,Arunaloke Chakrabarti The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p239 28 Accounting for non-adherence to assigned antibiotic treatment duration for bloodstream infection (BALANCE): a post-hoc analysis of a randomised clinical trial 血流感染抗生素治疗疗程依从性考量（BALANCE）：一项随机临床试验的事后分析 Sean W X Ong,Ruxandra Pinto,Robert K Mahar,Asgar Rishu,Joshua S Davis,Robert A Fowler,Steven Y C Tong,Nick Danemanfor the BALANCE trial consortium The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p250 29 Field evaluation of a rapid antigen test for mpox in the Democratic Republic of the Congo and Uganda: a multicentre, prospective, diagnostic accuracy study 刚果民主共和国和乌干达猴痘快速抗原检测的现场评估：一项多中心、前瞻性、诊断准确性研究 Barnabas Bakamutumaho,David Lupande Mwenebitu,Winters Muttamba,Ingrid Ampeire,Henry Kyobe Bosa,Esto Bahizire,Bertin Casinga Bisimwa,Andrew Obuku,Misaki Wayengera,Alison Sandeman,Matthew T G Holden,Patrick D M C Katoto,Bruce Kirenga,Deborah A Williamson,Wilber Sabiiti The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p260 30 Complications and mortality of typhoid fever: an updated global systematic review and meta-analysis 伤寒热的并发症与死亡率：一项更新的全球系统综述与荟萃分析 Shruti Murthy,Nienke N Hagedoorn,Suzanne Faigan,Meera D Rathan,Christian S Marchello,John A Crump The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p270 31 Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 1990-2023年全球、区域和国家层面查加斯病负担：2023年全球疾病负担研究的系统分析 GBD 2023 Chagas Disease and RAISE Study Collaborators The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p284 32 Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial 乌干达健康成年人中ChAdOx1裂谷热疫苗的安全性、耐受性和免疫原性：一项单中心、单盲、随机、安慰剂对照、剂量递增的1期试验 Zacchaeus Anywaine,Jennifer Serwanga,Abu-Baker Mustapher Ggayi,Andrew Max Abaasa,Daniel Wright,Ben Gombe,Peter Ejou,Tamara Namata,Antony Kigozi,Naboth Tukamwesiga,Vincent Basajja,Violet Ankunda,Dora Jocelyn Mulondo,Florence Nambaziira,Ayoub Kakande,Wilson Kakeeto,Phiona Nabaggala,Daniel Jenkin,Alison Lawrie,Pedro Folegatti,Nguyen Tran,Christian Hansen,Alison M Elliott,Adrian V S Hill,George M Warimwe,Pontiano Kaleebu The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p302 33 Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in children, adolescents, and adults in the USA: a randomised, observer-blind, placebo-controlled, phase 2 trial 美国儿童、青少年和成人基础免疫后18个月VLA15莱姆病疫苗候选物的加强免疫接种的免疫原性和安全性：一项随机、观察者盲法、安慰剂对照的2期试验 Laura Wagner,Michaela Obersriebnig,Romana Hochreiter,Vera Kadlecek,Julian Larcher-Senn,Lisa Hegele,Jason D Maguire,Timothy Murphy,Ulla Derhaschnig,Nicole Bézay,Juan Carlos Jaramillo,Susanne Eder-Lingelbach,Marc Messier The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p314 SERIES（研讨会） Artificial Intelligence and Infectious Diseases 人工智能与传染病 34 Artificial intelligence and infectious diseases: an evidence-driven conceptual framework for research, public health, and clinical practice 人工智能与传染病：基于证据的研究、公共卫生和临床实践概念框架 Anna Odone,Chiara Barbati,Silvia Amadasi,Tanja Schultz,David B Resnik The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e152 35 Artificial intelligence and infectious disease diagnostics: state of the art and future perspectives 人工智能与传染病诊断：现状与未来展望 Luca Miglietta,Timothy M Rawson,Ronald Galiwango,Alex Tasker,Damien K Ming,Darlington Akogo,Cecilia Ferreyra,Eric O Aboagye,N Claire Gordon,Carolina Garcia-Vidal,Jesus Rodriguez-Manzano,Alison H Holmes The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e168 36 Artificial intelligence and infectious diseases: tackling antimicrobial resistance, from personalised care to antibiotic discovery 人工智能与传染病：应对抗菌药物耐药性，从个性化治疗到抗生素发现 Alex Howard,Nada Reza,Peter L Green,Mo Yin,Erin Duffy,Henry C Mwandumba,Alessandro Gerada,William Hope The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e181 REVIEW（综述） 37 Community-acquired respiratory virus infections in patients with haematological malignancies or undergoing haematopoietic cell transplantation: updated recommendations from the 10th European Conference on Infections in Leukaemia 血液系统恶性肿瘤患者或接受造血细胞移植患者社区获得性呼吸道病毒感染：第10届欧洲白血病感染会议更新建议 Marie von Lilienfeld-Toal,Fareed Khawaja,Francesca Compagno,Christine Robin,José-Luis Piñana,Simone Cesaro,Hermann Einsele,Per Ljungman,David Navarro,Michael Boeckh,Roy F Chemaly,Hans H Hirsch The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e193 CLINICAL PICTURE（临床图像） 38 Mycoplasma hominis toe osteomyelitis: a rare and unusual bone infection 人型支原体足趾骨髓炎：一种罕见且不寻常的骨感染 Cheryl Keel,Pauleen McSherry,Rebecca Thombre,Sendurann Nadarajah,Rediat Tewolde,Owen B Spiller,Baharak Afshar The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e207 THE LANCET Infectious Diseases. Volume 26Number 4 柳叶刀传染病学 26卷 4期 https://www.thelancet.com/journals/laninf/issue/current EDITORIAL(社论) 1 GoGoVax dispels hopes for gonorrhoea vaccination GoGoVax让淋病疫苗的希望破灭 The Lancet Infectious Diseases The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p329 COMMENT（述评） 2 Do the benefits of universal screening outweigh the harms? 全民筛查的益处是否大于害处？ Alanna N Gillespie,Emma Webb,Valerie Sung The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p330 3 Chikungunya in Brazil: vaccination strategies informed by mathematical modelling 巴西基孔肯雅热：基于数学建模的疫苗接种策略 José Lourenço,Marta Giovanetti The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p331 4 Chikungunya adolescent vaccination and the distinct risk–benefit landscapes 青少年接种基孔肯雅热疫苗及独特的风险-获益情况 Ernesto T A Marques,Simon Barratt-Boyes The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p333 5 Circulation of clade Ib mpox outside of Africa—are we prepared? 非洲以外地区Ib分支猴痘的传播——我们准备好了吗？ Seth D Judson,Claude Kwe Yinda,Franziska K Kaiser,Daniel S Chertow,Emmie de Wit,James O Lloyd-Smith,Vincent J Munster The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p334 6 I worked at WHO: the USA leaving will not make America healthier 我曾在世卫组织工作：美国退出不会让美国更健康 Krutika Kuppalli The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p336 CORRESPONDENCE（读者来信） 7 Maternal views on RSV vaccination in the UK's second season 英国第二季呼吸道合胞病毒疫苗接种的产妇观点 Shaun O'Hagan,Steve Cunningham,Simon B Drysdale,Helen E Groves,Samantha Hunt,Dalia Iskander,Xinxue Liu,Mark D Lyttle,Chengetai D Mpamhanga,Thomas Waterfield,Thomas C Williams,Robin Marlow,Damian Rolandon behalf of the PERUKI & BronchStart/Stop Collaboration The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e209 8 Overcoming immune imprinting with the COVID-19 LP.8.1 mRNA boosters 利用COVID-19 LP.8.1 mRNA加强针克服免疫印记 Ninaad Lasrado,Annika Rössler,Katherine Molloy,Isabella McConnell,Ritobhas Bhowmik,Francisco Armando Granados-Contreras,Jessica Wu,Alejandra Waller-Pulido,Samuel J Nangle,Erica Borducchi,Ai-ris Y Collier,Dan H Barouch The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e212 CORRECTIONS（更正） 9 Correction to Lancet Infect Dis 2025; published online Nov 27.  https://doi.org/10.1016/S1473-3099(25)00605-X 《柳叶刀-传染病学》2025年刊载内容更正；在线发布于11月27日 The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e214 10 Correction to Lancet Infect Dis 2026; 26: 343–61 《柳叶刀-传染病学》2026年刊载内容更正；26卷：343-61页 The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e214 11 Correction to Lancet Infect Dis 2026; published online Jan 23. https://doi.org/10.1016/S1473-3099(25)00730-3 《柳叶刀-传染病学》2026年刊载内容更正；在线发布于1月23日 The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e214 12 Correction to Lancet Infect Dis 2026; published online Jan 28. https://doi.org/10.1016/S1473-3099(25)00747-9 《柳叶刀-传染病学》2026年刊载内容更正；在线发布于1月28日 The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e214 NEWSDESK（新闻台） 13 UK loses measles elimination status as cases rise 随着病例增加，英国失去麻疹消除地位 Priya Venkatesan The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e215 14 Brazil launches implementation study of lenacapavir 巴西启动来那卡帕韦实施研究 Tony Kirby The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e216 15 Clade Ib mpox in southwest Indian Ocean islands 西南印度洋岛屿出现Ib分支猴痘 Esther Nakkazi The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e217 16 EMA approves combined COVID-19 and flu mRNA vaccine 欧洲药品管理局批准COVID-19和流感联合mRNA疫苗 Talha Burki The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e218 17 Research in brief 研究简讯 Priya Venkatesan The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e219 OBITUARY（讣告） 18 Nicholas John White 尼古拉斯·约翰·怀特 Sanjeet Bagcchi The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p339 PROFILE（人物简介） 19 Katharina Kranzer—led by curiosity, committed to capacity 卡塔琳娜·克兰泽——受好奇心驱使，致力于提升能力 Tony Kirby The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p340 MEDIA WATCH（媒体观察） Film（电影） 20 Leishmaniasis: a story of two continents 利什曼病：两个大陆的故事 Vijay Shankar Balakrishnan The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p341 Book（书籍） 21 Finding your voice in a world of uncertainty 在不确定的世界中找到自己的声音 Carrie Fielden The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p342 ARTICLES（论著） 22 Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 1990-2023年下呼吸道感染的全球负担及病因：2023年全球疾病负担研究的系统分析 GBD 2023 Lower Respiratory Infections and Antimicrobial Resistance Collaborators GBD 2023下呼吸道感染和抗菌素耐药性协作组 The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p343 23 Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis 英国苏格兰地区母体RSVpreF疫苗对婴儿严重疾病的保护效果：一项全国性、基于人群的病例对照研究和队列分析 Isobel McLachlan,Chris Robertson,Kirsty E Morrison,Ross McQueenie,Safraj Shahul Hameed,Cheryl Gibbons,Rachael Wood,Rachel Merrick,Louisa Pollock,Antonia Ho,Ting Shi,Thomas C Williams,Sir Aziz Sheikh,Jim McMenamin,Sam Ghebrehewet,Kimberly Marsh The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p362 24 Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort study 法国儿童COVID-19后支原体肺炎感染的复现（ORIGAMI）：一项回顾性和前瞻性多中心队列研究 Anaïs Chosidow,Zoha Maakaroun-Vermesse,Vichita Ok,Cécile Delecroix,Pascal Le Roux,Marie-Aliette Dommergues,Justine de Larminat,Eric Jeziorski,Pauline Ronjat,Léa Jaume,Anne Welfringer-Morin,Cécile Bébéar,Maud Gits-Muselli,Delphine Viriot,Charles-Joris Roux,Stéphane Bechet,Anne-Sophie Romain,Mathie Lorrot,Robert Cohen,Corinne Levy,Jérémie F Cohenon behalf of the ORIGAMI Study Group The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p374 25 Lessons derived from a 3-year congenital cytomegalovirus screening programme in Israel: a prospective population-based cohort study 以色列先天性巨细胞病毒筛查项目的3年经验教训：一项前瞻性基于人群的队列研究 Smadar Eventov Friedman,Noa Ofek Shlomai,Esther Oiknine-Djian,Tal Sido,Oren Gordon,Sraya Greenberger,Hadar Horowitz,Lior Merav,Stav David Mehaber,Orit Caplan,Miriam Geal-Dor,Natalia Simanovsky,Diana Averbuch,Colin Kunzweiler,Yosefa Hefter,John Diaz-Decaro,Ora Paltiel,Moran Yassour,Dana G Wolf The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p384 26 Comparison of the performance and costs of testing algorithms using rapid diagnostic tests for detection and treatment of syphilis among pregnant individuals and men who have sex with men: a modelling study 使用快速诊断检测方法对孕妇和男男性行为者进行梅毒检测和治疗的不同检测算法的性能和成本比较：一项建模研究 Ying Zhang,Eric P F Chow,Lei Zhang,Christopher K Fairley,Jason J Ong The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p394 27 The epidemiology of chikungunya virus in Brazil and the potential impact of vaccines: a mathematical modelling study 巴西基孔肯雅热病毒的流行病学及疫苗的潜在影响：一项数学建模研究 Oscar Cortes-Azuero,Megan O'Driscoll,Gabriel Ribeiro dos Santos,Ronaldo de Jesus,Shirlene T S de Lima,Danny Scarponi,Christinah Mukandavire,Arminder Deol,Moritz U G Kraemer,William M de Souza,Henrik Salje The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p406 28 Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in adolescents: final results from a 12-month, double-blind, randomised, placebo-controlled, phase 3 trial in endemic areas of Brazil 青少年接种减毒活基孔肯雅热病毒疫苗的安全性和免疫原性：巴西流行地区一项为期12个月、双盲、随机、安慰剂对照的3期试验最终结果 Vera Buerger,Andrea Pfeiffer,Petra Schoengrundner,Jutta Seebacher,Romana Hochreiter,Karin Kosulin,Oliver Zoihsl,Petronela Weisova,Robert Mader,Ana Paula Loch,Eolo Morandi Jr,Mauricio Lacerda Nogueira,Carlos Alexandre Antunes de Brito,Julio Croda,Mauro Martins Teixeira,Ivo Castelo-Branco Coelho,Ricardo Gurgel,Allex Jardim da Fonseca,Marcus Vinícius Guimarães de Lacerda,Edson Duarte Moreira Jr,Ana Paula Rocha Veiga,Susanne Eder-Lingelbach,Juan Carlos Jaramillo The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p417 29 National burden of and optimal vaccine policy for Japanese encephalitis virus in Bangladesh: a seroprevalence and modelling study 孟加拉国日本脑炎病毒的全国负担及最佳疫苗接种政策：一项血清流行率和建模研究 Mariana Perez Duque,Kishor K Paul,Rebeca Sultana,Gabriel Ribeiro dos Santos,Megan O'Driscoll,Abu M Naser,Mahmudur Rahman,Mohammad Shafiul Alam,Hasan M Al-Amin,Mohammed Z Rahman,Mohammad E Hossain,Repon C Paul,Elias Krainski,Stephen P Luby,Simon Cauchemez,Jessica Vanhomwegen,Emily S Gurley,Henrik Salje The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p429 REVIEW（综述） 30 Autoantibodies in long COVID: a systematic review 长新冠中的自身抗体：一项系统综述 Fabian Wilhelm,Janne Cadamuro,Sylvia Mink The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e220 31 Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE) 登革热临床试验核心结局测量指标集：一项国际德尔菲共识研究（DEN-CORE） Sophie Yacoub,Anastasia Demidova,Xin Hui S Chan,Ali Ajam,Dina Baimukhambetova,Andreij Horn,Evgeniia Kakotkina,Mark Kosenko,Aigun Mursalova,Jennifer Ilo Van Nuil,Chi Le Phuong,Lin Xiao,Sudeep Adhikari,Juan David Alzate Alvarez,Kathryn B Anderson,Panisadee Avirutnan,Stephanie Buchholz,Richa Chandra,Aileen Y Chang,Ho Quang Chanh,Mónika Patricia Consuegra Rodríguez,Vanessa Daniel,Janet V Diaz,Claudia Figueiredo-Mello,Rosa Margarita Gelvez-Ramírez,Tran Bang Huyen,Evelyne Kestelyn,Phung Khanh Lam,Stije J Leopold,Ruobing Li,Tran Luu,David Chien Boon Lye,Angela McBride,Isabelle Meyer-Andrieux,Nathaniel J Moorman,Nguyet Minh Nguyen,Sharifah Faridah Syed Omar,Hang Cheng Ong,Eng Eong Ooi,Ekaterina Pazukhina,Sarah L Pett,Diego Bastos Porto,Giri S Rajahram,Marc Rogers,Elsa Rojas,James Rosen,Jamie Rylance,William H K Schilling,Andre M Siqueira,Peter Sjö,Alfonso Sucerquia-Hernandez,Dong Thi Hoai Tam,Mauro Martins Teixeira,Andreas Tietz,Huynh Trung Trieu,Annalise Unsworth,Luis Villar,Adam Tully Waickman,James A Watson,Bridget A Wills,Po Ying Chia,Patricia Brasil,Thomas Jaenisch,Lucy Lum,Gathsaurie Neelika Malavige,Steven McGloughlin,Bharath Kumar Tirupakuzhi Vijayaraghavan,Laura Merson,Daniel Munblitthe DEN-CORE Study Group The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e231 PERSONAL VIEW（个人观点） 32 Breaking the under-reporting cycle for zoonotic diseases in low-income and middle-income countries through national-level integration of community-based surveillance and response: insights from Cameroon, Chad, Côte d’Ivoire, and Mali 通过国家层面整合社区监测和响应，打破低收入和中等收入国家人畜共患病报告不足的循环：来自喀麦隆、乍得、科特迪瓦和马里的见解 Katherine E L Worsley-Tonks,Mahamat Fayiz Abakar,Zanan Coulibaly,Marie Paulette Deya-Yang,Linda Esso,Jean Marc Kameni Feussom,Vessaly Kallo,Zakaria Keita,Monique Lechenne,Magloire Tchamba Kombou,Inès Emah Manda,Christiane Mangou,Stephanie Mauti,Aime Gilert Mbonda Noula,Rodrigue Poueme Namegni,Perrine Parize,Mathurin Cyrille Tejiokem,Isaac Tiembre,Abdallah Traoré,Jakob Zinsstag,Hervé Bourhy The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e245 GRAND ROUND（大查房） 33 Paediatric case of invasive group A streptococcal necrotising myositis: diagnostic challenges and lessons learned 儿童侵袭性A组链球菌坏死性肌炎病例：诊断挑战和经验教训 Suraya Yusuf,Michael James Carter,Jenny Woodruff,Peter Kalu,Justin Conrad Rosen Wormald,Claire Sethu The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e259 CLINICAL PICTURE（临床图像） 34 Bullous haemorrhagic cellulitis caused by Escherichia coli in a patient with cirrhosis 肝硬化患者由大肠杆菌引起的大疱性出血性蜂窝织炎 Irene Rivera-Ruiz,Paloma Elma Alañón-Martínez,Elisa Vidal-Verdú The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e268 THE LANCET Infectious Diseases. Volume 26Number 5 柳叶刀·传染病学26卷 5期 https://www.thelancet.com/journals/laninf/issue/current EDITORIAL(社论) 1 How are vaccine recommendations made? 疫苗建议是如何制定的？ The Lancet Infectious Diseases The Lancet Infectious Diseases. May 2026，Vol 26(5)：p439 COMMENT（述评） 2 First efficacy evidence for a multistage malaria vaccine targeting infection and transmission 针对感染和传播多阶段的疟疾疫苗首次显示出有效性证据 Gemma Moncunill,Carlota Dobaño The Lancet Infectious Diseases. May 2026，Vol 26(5)：p440 3 Lassa viral dynamics: implications for missed diagnosis 拉沙病毒动态：对漏诊的影响 Chinwe Lucia Ochu,William Douglas Evans The Lancet Infectious Diseases. May 2026，Vol 26(5)：p441 4 Nirsevimab over two RSV seasons: do the findings align with expectations? 两个呼吸道合胞病毒（RSV）季节中Nirsevimab的应用情况：研究结果是否符合预期？ Corinne Levy,Robert Cohen The Lancet Infectious Diseases. May 2026，Vol 26(5)：p443 5 Improving antimalarial therapeutic efficacy studies 提高抗疟治疗疗效研究的质量 Philip J Rosenthal The Lancet Infectious Diseases. May 2026，Vol 26(5)：p444 6 The case for routine patient review in long COVID research 在长期新冠研究中开展常规患者评估的理由 Letícia Soares,C H Romatowski,Gina Assaf,Chloé de Canson The Lancet Infectious Diseases. May 2026，Vol 26(5)：p446 CORRESPONDENCE（读者来信） 7 When mpox is not mpox: varicella and measles in DR Congo 当猴痘并非猴痘时：刚果民主共和国的水痘和麻疹病例 Levi Bugwaja,Nathan Banzi,Trust Faraja Mukika,Patrick Kazuba Bugale,Patrick Musole Bugeme,Emmanuel Biragi Nzenze,Heshima Lajeri Nzirimo,Salomon Mashupe Shangula,Justin Bengehya,Willy Kasi,Krutika Kuppalli,Camille Escadafal,Daniel Mukadi-Bamuleka,Jackie Knee,Jules Jackson,Elizabeth C Lee,Andrew S Azman,Espoir Bwenge Malembaka The Lancet Infectious Diseases. May 2026，Vol 26(5)：e209 8 Mpox virus in human breastmilk and tecovirimat pharmacokinetics: implications for postnatal transmission 人乳中的猴痘病毒及特考韦瑞药代动力学：对产后传播的影响 Francesca Colavita,Massimo Tempestilli,Silvia Meschi,Carla Pittini,Martina Rueca,Giuseppe Sberna,Fabrizio Carletti,Simone Lanini,Silvia Cammisa,Giulia Paviotti,Lorenza Driul,Miriam De Vito,Cesare Ernesto Maria Gruber,Marco Cotrufo,Eleonora Cimini,Valentina Mazzotta,Andrea Antinori,Carlo Tascini,Fabrizio Maggi,Licia Bordi The Lancet Infectious Diseases. May 2026，Vol 26(5)：e211 CORRECTIONS（更正） 9 Correction to Lancet Infect Dis 2026; 26: 522–34 对《柳叶刀-传染病》2026年第26卷第522–34页的更正 The Lancet Infectious Diseases. May 2026，Vol 26(5)：e213 NEWSDESK（新闻台） 10 New WHO recommendations for tuberculosis diagnosis 世卫组织新的结核病诊断建议 Timothy Jesudason The Lancet Infectious Diseases. May 2026，Vol 26(5)：e214 11 New report assesses antimicrobial pipeline 新报告评估抗菌药物研发管线 Manjulika Das The Lancet Infectious Diseases. May 2026，Vol 26(5)：e215 12 Meningitis B outbreak in England 英格兰B型脑膜炎暴发 Tony Kirby The Lancet Infectious Diseases. May 2026，Vol 26(5)：e216 13 WHO reports on health of migrants and refugees 世卫组织发布移民和难民健康报告 Talha Burki The Lancet Infectious Diseases. May 2026，Vol 26(5)：e217 14 Research in brief 研究简讯 Priya Venkatesan The Lancet Infectious Diseases. May 2026，Vol 26(5)：e218 OBITUARY（讣告） 15 Christian C Patrick 克里斯蒂安·C·帕特里克 Sanjeet Bagcchi The Lancet Infectious Diseases. May 2026，Vol 26(5)：p448 PROFILE（人物简介） 16 Eizo Takashima—developing a new class of malaria vaccines 高石荣三——开发新型疟疾疫苗 Tony Kirby The Lancet Infectious Diseases. May 2026，Vol 26(5)：p449 MEDIA WATCH（媒体观察） Book（书籍） 17 Feminism and the AIDS epidemic 女权主义与艾滋病流行 Charlotte Day The Lancet Infectious Diseases. May 2026，Vol 26(5)：p450 ARTICLES（论著） 18 Efficacy of ProC6C-AlOH/Matrix-M against Plasmodium falciparum infection and mosquito transmission: a phase 2, randomised, controlled human malaria infection study ProC6C-AlOH/Matrix-M预防恶性疟原虫感染和蚊子传播的有效性：一项2期随机对照人体疟疾感染研究 Mamady Kone,Jordan Plieskatt,Moussa Thienta,Bourama Kamate,Ebenezer A Ofori,Markus Gmeiner,Bayaya Haidara,Moussa B Kanoute,Bakary Traore,Ousmane A Poudiouguo,Hawa S Bayogo,Ibrahim Diarra,Karim Bengaly,Amatigue Zeguime,Daman Sylla,Adama Sacko,Stephen L Hoffman,Matthew B B McCall,Michael Theisen,Issaka Sagaraon behalf of the ProC6C Study Group The Lancet Infectious Diseases. May 2026，Vol 26(5)：p451 19 The effectiveness of long-lasting spatial repellent emanators against malaria in humanitarian crisis settings in northern Nigeria: a two-arm pragmatic, open-label, controlled trial 长效空间驱蚊剂在尼日利亚北部人道主义危机环境中预防疟疾的有效性：一项双臂实用、开放标签、对照试验 Richard James Allan,Ramona Scherrer,Sara Estecha-Querol,David Weetman,Laura Paris,Umar Ba'abba Goni,Fatima Idris Abdulhamid,Blaise Nfornuh Alenwi,Sajjad Ahmad,Chad L Cross,Garba Mohammed Ashir,Mala Waziri,Godwin Ntadom,Louisa Alexandra Messenger The Lancet Infectious Diseases. May 2026，Vol 26(5)：p464 20 Lassa fever symptomatology, viral dynamics, and host immune response (PREPARE): a prospective, observational cohort study in Liberia 拉沙热症状、病毒动态和宿主免疫反应（PREPARE）：利比里亚一项前瞻性观察队列研究 David A Wohl,Carwolo Pewu,Chanhwa Lee,Emmanuel Kerkula,Martha Gayflowu,Nukal Doetein,Katie R Mollan,Taylor J Krajewski,Becky Straub,Alfred Flomo,Amara Fofana,Stanley Kerkula,Thomas Sumo,Alexander Sampson,Samuel Vouh,Fred Flomo,McKenzie A Colt,Thomas Remont,Eleanor Rose Watts,Marta Zizek,Catherine Nimely,Minnie Ricks,Jefferson Sibley,William A Fischer II The Lancet Infectious Diseases. May 2026，Vol 26(5)：p475 21 Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled study B群链球菌疫苗（GBS-AlpN）在孕妇及其婴儿中的免疫原性和安全性：一项2期、多中心、观察者设盲、随机、安慰剂对照研究 Paul T Heath,Ntokozo Zuma-Gwala,Rikke Bek Helmig,Elizea Horne,Anette Kjærbye-Thygesen,Mie Korslund Wiinblad Crusell,Maphoshane Nchabeleng,Renate Strehlau,Mohammed R Khalil,Christine E Jones,Jorne Biccler,Jeannett Dimsits,Bengt Johansson-Lindbom,Per B Fischer,Lidia Oostvogels,Shabir A Madhion behalf of the MVX0004 study group The Lancet Infectious Diseases. May 2026，Vol 26(5)：p486 22 Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trial 单剂量口服减毒霍乱活疫苗PanChol的安全性和免疫原性：一项1a期、双盲、随机、安慰剂对照试验结果 Deborah R Leitner,Stephen R Walsh,Masataka Suzuki,Michaël Desjardins,Alisse Hannaford,Amy C Sherman,Hannah Levine,Lena Carr,Elliot Hammerness,Akina Osaki,Emily Sullivan,Bryan Wang,George I Balazs,Jun Bai Park Chang,Damien M Slater,Nirajan Puri,Carole J Kuehl,Wilbur H Chen,Jason B Harris,Steven Piantadosi,Lindsey R Baden,Matthew K Waldoron behalf of the PanChol study group The Lancet Infectious Diseases. May 2026，Vol 26(5)：p497 23 Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial 晚期艾滋病患者使用整合酶抑制剂与蛋白酶抑制剂治疗（LAPTOP）：一项多国、随机、开放标签、非劣效性试验 Georg M N Behrens,Lambert Assoumou,Geoffroy Liegeon,Andrea Antinori,Rafael Micán,Francesco G Genderini,Frank A Post,Jürgen K Rockstroh,Lisa Hamzah,Pere Domingo,Adrian Curran,Montserrat Laguno,Carl Fletcher,Jack Moody,Anton Pozniakon behalf of the NEAT-ID Foundation,and LAPTOP Study Team The Lancet Infectious Diseases. May 2026，Vol 26(5)：p510 24 Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study 在西班牙加利西亚婴儿中进行Nirsevimab普遍预防，对横跨两个呼吸道合胞病毒季节的医院和初级保健结果的影响（NIRSE-GAL）：一项基于人群的前瞻性观察研究 Josefina L Razzini,Iago Giné-Vázquez,Jing Jin,María-Isolina Santiago-Pérez,Olaia Pérez-Martínez,María-Teresa Otero-Barrós,Nuria Suárez-Gaiche,Rolf Kramer,Leticia Platero-Alonso,Rosa-María Álvarez-Gil,Olga-María Ces-Ozores,Victoria Nartallo-Penas,Susana Mirás-Carballal,Marta Piñeiro-Sotelo,Juan-Manuel González-Pérez,Carmen Rodríguez-Tenreiro-Sánchez,Ángela Manzanares-Casteleiro,Ana Dacosta-Urbieta,Cintia Álvarez-Smith,Irene Rivero-Calle,Antonio Salas,Carmen Durán-Parrondo,Narmeen Mallah,Federico Martinón-Torres The Lancet Infectious Diseases. May 2026，Vol 26(5)：p522 25 Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled study CRS3123治疗成人艰难梭菌感染初次发作或首次复发的安全性和有效性：一项2期、随机、双盲、多中心、万古霉素对照研究 Thomas Louie,Wendy Ribble,Louis Boccumini,Katherine Johnson,Mary A De Groote,Joshua Day,Clifford Mason,Xicheng Sun,Jane Freeman,Kenan Gu,Glenn Tillotson,Mark H Wilcox,Nebojsa Janjic,Thale C Jarvis,Seema U Nayak,Urs A Ochsner,Jon B Bruss The Lancet Infectious Diseases. May 2026，Vol 26(5)：p535 REVIEW（综述） 26 The Emerging Resistance Index: tracking early resistance to new antibiotics 新兴耐药指数：追踪新抗生素的早期耐药性 Jacopo Garlasco,Fabiana Arieti,Matteo Morra,Maela Tebon,Diego Ortiz,Maria Diletta Pezzani,Karin Odoj,Federica Manco,Alessandro Cassini,Stephan Harbarth,Elisabeth Presterl,Biljana Carevic,Gunnar Kahlmeter,Karin Thursky,Paola Morelli,Stefan Hagel,Alessia Savoldi,Evelina Tacconelli The Lancet Infectious Diseases. May 2026，Vol 26(5)：e219 27 Kyasanur Forest disease: an emerging arboviral threat 基萨努尔森林病：一种新兴的虫媒病毒威胁 Neha Pandey,Sunit K Singh The Lancet Infectious Diseases. May 2026，Vol 26(5)：e228 PERSONAL VIEW（个人观点） 28 Reconsidering the clinical assessment of resistance to slowly eliminated antimalarial drugs in high-transmission settings 重新考虑高传播地区对缓慢消除抗疟药物耐药性的临床评估 Nicholas J White,James A Watson The Lancet Infectious Diseases. May 2026，Vol 26(5)：e240 GRAND ROUND（大查房） 29 Safe delivery of intensive care for Marburg virus disease in Rwanda 卢旺达安全实施马尔堡病毒病重症监护 Eric Seruyange,Ernest Nahayo,François Xavier Uwimana,Joseph Biramahire,Fidele Hakorimana,Menelas Nkeshimana,David Turatsinze,Anselme Bizimana,Hassan Mugabo,Bosco Burakari,Ryan P Westergaard,Louise Mwiseneza,Nicholas Niyigaba,Jean Pierre Sibomana,Tsion Firew,Lambert Ingabire,Gaston Nyirigira,Etienne Kayigi,Evariste Mushuru,Marie Grace Niwemuhoza,Marie Grace Niyonizeye,Gisele Isingizwe,Josué Bongwa Rwibutso,Jean Pierre Nzabana,Gentil Semahoro Ndayishimiye,Déo Kimalarungu Ntakambirwa,Serge Kazindu,Halifa Ndayisabye,Eric Remera,Leon Mutesa,Jean Paul Rwabihama,Muhammed Semakula,Robert Fowler,Ruggero Giuliani,Jacob Goldberg,Frederique Jacquerioz,Janet Diaz,Amanda Rojek,Claude M Mambo,Yvan Butera,Sabin Nsanzimana,Elizabeth O Moreton,Thomas E Fletcher,William A Fischer 2nd,Théogène Twagirumugabe The Lancet Infectious Diseases. May 2026，Vol 26(5)：e248 CLINICAL PICTURE（临床图像） 30 Disseminated fusariosis arising from onychomycosis in a haematopoietic transplant recipient 造血干细胞移植受者甲癣引发的播散性镰刀菌病 Wouter A A de Steenhuijsen Piters,Man Wai Tang,Inge A H van den Berk,M E Baarsma,Karin van Dijk The Lancet Infectious Diseases. May 2026，Vol 26(5)：e256 THE LANCET Infectious Diseases. Volume 26Number 6 柳叶刀·传染病学26卷 6期 https://www.thelancet.com/journals/laninf/issue/current Editorial（社论） 1 The value of infectious disease conferences 传染病会议的价值 The Lancet Infectious Diseases The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p549 Comment（述评） 2 From emergency to integration: research as the bridge in mpox control 从紧急应对到整合：作为猴痘防控的桥梁的研究 Yap Boum,Mosoka Fallah,Michel Muteba,Henry Kyobe Bosa,Kyeng Mercy,John Misaki Wayengera,Bruce Kirenga,John Otshudiema,Placide Mbala,Marie-Roseline Belizaire,Ngashi Ngongo,Jean Kaseya The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p550 3 Strength of ATLAS or lady luck in a sepsis management trial? 脓毒症治疗试验，是ATLAS的力量还是幸运女神的眷顾？ Mojdeh Azimi,Dick Menzies The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p552 4 Reimagining radical cure for Plasmodium vivax 重新构思间日疟原虫的根治方案 Pyae Linn Aung,Liwang Cui The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p554 5 Does BA.3.2 epidemiology imply a change in SARS-CoV-2 evolution? BA.3.2的流行病学是否意味着SARS-CoV-2进化方向的改变？ Lu Zhang,Markus Hoffmann,Stefan Pöhlmann The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p555 Correspondence（读者来信） 6 Concerns regarding study of spatial emanators for malaria control 关于研究用于疟疾防控的空间传播因子的担忧 John Bradley,Richard Hayes,Peter G Smith,Immo Kleinschmidt The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e209 7 Concerns regarding study of spatial emanators for malaria control – Authors' reply 关于疟疾防控中空间散发器研究的关切——作者回复 Richard James Allan,Chad L Cross,Louisa Alexandra Messenger The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e210 Newsdesk（新闻台） 8 Bangladesh launches measles vaccine drive amid outbreak 孟加拉国在疫情期间启动麻疹疫苗接种运动 Samaan Lateef The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e211 9 Tecovirimat no longer approved for mpox in the EU 欧盟不再批准替可韦利马用于猴痘治疗 Sanjeet Bagcchi The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e212 10 Highlights of ESCMID Global 2026 2026年ESCMID全球大会亮点 Syeda Saleha Hassan The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e213 11 Global vaccination drive reaches 18.3 million children 全球疫苗接种运动已覆盖1830万儿童 Timothy Jesudason The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e214 12 Israel accused of using “water as a weapon” in Gaza 以色列被指控在加沙"以水为武器" Talha Burki The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e215 13 Research in brief 研究简报 Priya Venkatesan The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e216 Obituary（讣告） 14 James Phillip Luby 詹姆斯·菲利普·卢比 Sanjeet Bagcchi The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p558 Profile（人物介绍） 15 Daniela Hozbor—raising the bar for pertussis vaccines 丹妮拉·霍兹博尔——提升百日咳疫苗标准 Tony Kirby The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p559 Media Watch（媒体观察） Book（书籍） 16 Building bridges 搭建桥梁 Hollie Sherwood-Martin The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p560 Articles（论著） 17 Safety of MVA-BN vaccine in health-care personnel in DR Congo: a prospective cohort study MVA-BN疫苗在刚果（金）医务人员中的安全性：前瞻性队列研究 Faisal S Minhaj,Anna Mandra,Béatrice U Nguete,Toutou Likafi,Gaston Kokola,Stephanie Tran,Jordan L Kennedy,Benjamin Monroe,Christine M Hughes,Taina Joseph,Marissa K Person,Michael B Townsend,Panayampalli S Satheshkumar,Joelle Kabamba,Mary G Reynolds,Agam K Rao,Dorah Kasongo,Patricia A Yu,Yon Yu,Robert Shongo Lushima,Didine Kaba,Brett Petersen,Andrea M McCollum The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p561 18 Immunogenicity and safety of MVA-BN vaccine administered 5 years after a two-dose primary series in DR Congo: a prospective cohort study 两剂基础免疫后5年接种MVA-BN疫苗的免疫原性和安全性：刚果（金）前瞻性队列研究 Lalita Priyamvada,Faisal S Minhaj,Toutou Likafi,Elisabeth Pukuta,Elisabeth Muyamuna,William C Carson,Margaret Moriarty,Sergio Rodriguez,Taina Joseph,Joelle Kabamba,Gaston Kokola,Robert Shongo Lushima,Jean-Jacques Muyembe-Tamfum,Christine M Hughes,Brett W Petersen,Yon Yu,Agam Rao,Andrea M McCollum,Didine K Kaba,Beatrice U Nguete,Panayampalli S Satheshkumar,Michael B Townsend The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p571 19 A combined ELISA for infection-induced and vaccine-induced mpox antibodies during the clade Ib outbreak in Rwanda: an observational, cross-sectional, clinical validation study 伊布分支疫情期间卢旺达猴痘感染诱导和疫苗诱导抗体联合ELISA检测：观察性横断面临床验证研究 Jenny Clarke,Herve Semukunzi,Sian E Faustini,Jennifer L J Heaney,Hin Fai Kwok,Jean Marie Vianney Uwimana,Karishma Gokani,Gilbert Rukundo,Jean Pierre Musabyimana,Prosper Ingabire,Leopold Bitunguhari,Jean de Dieu Harelimana,Alex G Richter,Claude M Muvunyi,Christopher A Greenand the MpoxCARE Study Team The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p581 20 Case presentation of patients hospitalised with mpox (subclade Ib/2023sh) including children, adolescents, and adults in South Kivu, Democratic Republic of the Congo: an observational cohort study 刚果（金）南基伍省住院猴痘患者（伊布亚分支/2023sh）病例报告，包括儿童、青少年和成人：观察性队列研究 Luis Flores Girón,Gustavo Sganzerla Martinez,Baganda Ntahuma Daniel,Alfred Kesheni Bisimwa,Nkonzi Pacific,Georges Assumani Martin,Jean Christian Amini Kabwana,Anuj Kumar,Ali Toloue Ostadgavahi,Mansi Dutt,Kawaya Lusante Bénite,Mangura Hamuli Damien,Christian Gortázar,Bahaa Abu-Raya,Alyson A Kelvin,Kaleme Kiswele Prince,David J Kelvin The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p590 21 Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2×2 factorial, superiority trial 坦桑尼亚和乌干达HIV相关脓毒症的即时或高剂量抗结核治疗（ATLAS）：一项3期、开放标签、随机对照、2×2析因、优效性试验 Scott K Heysell,Stellah G Mpagama,Edwin Nuwagira,Bibie Said,Mark Conaway,Megan Null,Tania A Thomas,David R Boulware,Eva Otoupalova,Rinah Arinaitwe,Rhina Mushagara,Louisa Edwards,Peter Buzaare,Athumani M Ngoma,Davis Muganzi,Geofrey Gidoi,Samuel Jjunju,Antony Gulinja,Arestaricky G Rimoy,Fredrick C Mwita,Jeremiah Kidola,Oscar Atwiine,David Ocaaki,Dalton K Munyambalu,Jie Liu,Lucas Ampaire,Buliga Mujaga,Prakruti Rao,Alphonce Liyoyo,Margaretha Sariko,Conrad Muzoora,Christopher C Moore The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p601 22 Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial 7天高剂量伯氨喹和单剂量他芬诺奎与14天低剂量伯氨喹治疗间日疟原虫疟疾的有效性和安全性（EFFORT）：一项多中心、开放标签、随机对照、优效性试验 Tamiru Shibiru Degaga,Ayodhia Pitaloka Pasaribu,Rupam Tripura,Najia Ghanchi,Megha Rajasekhar,Bipin Adhikari,Benedikt Ley,Samuel Alemu Bamboro,Fareeha Abdul Jabbar,Nurfadhilah Hasibuan,Tedla Teferi Tego,Shane Zehra,Bushra Qurashi,Hellen Mnjala,Grant Lee,Peixuan Li,Abdul Momin Kazi,Widaya Safitri,Yulita Yulita,Dedi Sahat Parningotan Siagian,Deni Syahputra,Halik Hadi,Taj Muhammad,Amna Ibrahim,Nasreen Syed,Khuda Dost,Agatha Mia Puspitrasari,Pinkan Pertiwi Kariodimedjo,Anjana Rai,Angela Rumaseb,Edwin Sutanto,Mom Ean,Asia Khan,Meas Sokha,Robert James Commons,Sophie Weston,Rintis Noviyanti,Tom Peto,James J Callery,Umair Ali,Tariq Mehmood,Arjen Dondorp,Angela Devine,Ery Setiawan,Muthoni Mwaura,Sarah Cassidy-Seyoum,Rodas Temesgen,Dagimawie Tadesse Abate,Eyerusalem Beyene Erjabo,Geremew Gashaw Gessa,Fitsum Getahun Kiros,Muhammad Imran Usmani,Ali Raza,Adugna Woyessa,Asrat Hailu,Julie A Simpson,Amalia Karahalios,Mohammad Asim Beg,Lorenz von Seidlein,Lek Dysoley,Sarah Auburn,Ric N Price,Kamala Thriemer The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p614 23 Efficacy of ETVAX, a vaccine against enterotoxigenic Escherichia coli-positive diarrhoea in Gambian children: a double-blind, randomised, placebo-controlled, phase 2b trial ETVAX疫苗对冈比亚儿童产肠毒素大肠杆菌阳性腹泻的有效性：一项双盲、随机、安慰剂对照、2b期试验 M Jahangir Hossain,Fatou Secka,Lady C Sanyang,Raifu Taiwo,Emmanuel C Okoh,Olubunmi A Olubiyi,Mbemba Drammeh,Emmanuel U Richard,Ahmed D Balami,Mama Drammeh,Samba Juma Jallow,Bakary Sonko,Paticia Ezedimbu-Michael,Jacinta Obiaduo,Ousman Secka,Joanna Kaim,Björn Sjöstrand,Agneta Lissmats,Nils Carlin,Umberto D'Alessandro,Ann-Mari Svennerholm,Thomas F Wierzba The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p627 24 Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trial 伤寒和副伤寒A沙门氏菌结合疫苗候选物在欧洲健康成人中的安全性和免疫原性：1期随机对照试验 Ilse De Coster,Mohammad AbdelGhany,Eleanna Sarakinou,Chiara Fineschi,Elisa Marchetti,Rita La Gaetana,Simona Nigro,Martina Carducci,Luisa Massai,Valentino Conti,Omar Rossi,Giulia Luna Cilio,Alimamy Serry-Bangura,Pietro Tessitore,Pierre Van Damme,Kanchanamala Withanage,Francesca Micoli,Francesco Berlanda Scorza,Simona Rondini,Usman N Nakakana,Ashwani Kumar Arora The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p638 Review（综述） 25 British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 update 英国医学真菌学会严重真菌病诊断最佳实践建议：2025年更新 Silke Schelenz,Alireza Abdolrasouli,Darius Armstrong-James,H Ruth Ashbee,Richard Barton,Tihana Bicanic,Andy Borman,Lottie Brown,Chris Eades,Laura Ferreras-Antolin,Rebecca Gorton,Ronan McMullan,Iain Page,Nelun Perera,Riina Rautemaa-Richardson,Johannes Wagener,P Lewis White,David W Denning The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e217 26 Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia 血液系统恶性肿瘤或造血干细胞移植后发热性中性粒细胞减少患者的经验性和目标性抗菌治疗：第10届欧洲白血病感染会议建议 Dina Averbuch,Yuri Vanbiervliet,Francesco Baccelli,Malgorzata Mikulska,Dionysios Neofytos,Carolina Garcia-Vidal,Manuela Aguilar-Guisado,Nicole Blijlevens,Patricia Munoz,Catherine Cordonnier,Murat Akova,Thierry Calandra The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e232 Personal View（个人观点） 27 Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development 结核病治疗的未来保障：药物与耐药性检测协同开发框架 Francesca Saluzzo,Seda Yerlikaya,Susan Elizabeth Dorman,Kathleen Eisenach,Maha Reda Farhat,Nazir Ismail,Christian Lienhardt,Timothy M Walker,Fatima Jones,Ana Yepes,Adam Penn-Nicholson,Morten Ruhwald,Bavesh Kana,Claudia Maria Denkinger,Daniela Maria Cirillo The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e248 Grand Round（大查房） 28 Below-knee amputation following osteomyelitis from multidrug-resistant Stenotrophomonas maltophilia in a diabetic foot ulcer 糖尿病足溃疡中多重耐药嗜麦芽窄食单胞菌骨髓炎致膝下截肢 Alejandro Arbona-Lampaya,Ricardo A Pérez-Ojeda,Melanie Santos-Marrero,Adrián Pérez-Aybar The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e257 Clinical Picture（临床图像） 29 Severe inguinal bubo and haemorrhagic exanthem in autochthonous clade Ib mpox 本土伊布分支猴痘导致的严重腹股沟淋巴结肿大和出血性皮疹 Patrick E Obermeier,Philipp Schulz,Hartmut Stocker,Ingo Ochlast,Livia Schrick,Annika Brinkmann,Pascal Migaud The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e266

THE LANCET Infectious Diseases. Volume 26Number 1 柳叶刀传染病学 26卷 1期 https://www.thelancet.com/journals/laninf/issue/current EDITORIAL(社论) 1 Urgent need for infection prevention and control in prisons 监狱中感染预防和控制的迫切需求 The Lancet Infectious Diseases The Lancet Infectious Diseases Vol 26(1):p1 COMMENT（述评） 2 Now is the time to integrate serology into routine infectious disease surveillance 现在是时候将血清学纳入常规传染病监测了 Simon Cauchemez The Lancet Infectious Diseases Vol 26(1):p2 3 Reassessing sotrovimab's role in COVID-19: insights and implications 重新评估索托维单抗在新冠肺炎治疗中的作用：见解与启示 Daniele Focosi,Fabrizio Maggi The Lancet Infectious Diseases Vol 26(1):p3 4 Shaping opportunities for future clinical trials in tuberculosis 为未来结核病临床试验创造机会 Ivan Noreña,Beno Mbeya,Joanitah Nalunjogi,Ombeni Chimbe,Norbert Heinrich The Lancet Infectious Diseases Vol 26(1):p5 5 Diversifying antimalarial treatment for uncomplicated Plasmodium falciparum malaria in Uganda 乌干达针对无并发症恶性疟原虫疟疾的抗疟治疗多样化 Arjen M Dondorp The Lancet Infectious Diseases Vol 26(1):p6 6 A safe start for PfSPZ Vaccine, but efficacy in children remains elusive PfSPZ疫苗安全起步，但在儿童中的疗效仍难以捉摸 Nicholas Aderinto,Temitomi Jane Oyedele The Lancet Infectious Diseases Vol 26(1):p8 7 Rifasutenizol-based triple therapy for Helicobacter pylori infection 以利法苏替尼唑为基础的三联疗法治疗幽门螺杆菌感染 Jinnan Chen,Hong Lu The Lancet Infectious Diseases Vol 26(1):p9 8 The smallest faith 最渺小的信念 Steven A Pergam The Lancet Infectious Diseases Vol 26(1):p11 9 Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease 新冠肺炎长期症状临床试验的阴性结果：为异质性疾病选择预后指标 Lara Goxhaj,Lisa McCorkell,Femke van Rhijn-Brouwer,Letícia Soares,Julia Moore Vogel,Chloé de Canson The Lancet Infectious Diseases Vol 26(1):p13 10 Strengthening global preparedness and response to arboviral disease threats: a call to action 加强全球应对虫媒病毒疾病威胁的准备和响应：行动呼吁 WHO Global Arbovirus Initiative Technical Advisory Group 世界卫生组织全球虫媒病毒倡议技术咨询小组 The Lancet Infectious Diseases Vol 26(1):p15 11 Introducing our cover artist for 2026: Daria Lada 介绍我们2026年的封面艺术家：达里亚·拉达 Marco De Ambrogi The Lancet Infectious Diseases Vol 26(1):p17 Correspondence（读者来信） 12 Epidemiological and virological update on the emerging SARS-CoV-2 variant BA.3.2 新兴新冠病毒变异株BA.3.2的流行病学和病毒学最新情况 Lu Zhang,Nianzhen Chen,Amy Eichmann,Inga Nehlmeier,Anna-Sophie Moldenhauer,Metodi V Stankov,Christine Happle,Alexandra Dopfer-Jablonka,Georg M N Behrens,Markus Hoffmann,Stefan Pöhlmann The Lancet Infectious Diseases Vol 26(1):e1 13 Effects of LP.8.1-adapted mRNA vaccination on SARS-CoV-2 variant neutralisation Christine Happle,Markus Hoffmann,Metodi V Stankov,Inga Nehlmeier,Amy Eichmann,Torsten LP.8.1适应性mRNA疫苗接种对新冠病毒变异株中和作用的影响 Witte,Luis Manthey,Stefan Pöhlmann,Alexandra Dopfer-Jablonka,Georg M N Behrens The Lancet Infectious Diseases Vol 26(1):e3 14 Artificial intelligence and spillover prediction: aligning innovation with empirical reality in One Health surveillance 人工智能与溢出预测：在“同一健康”监测中使创新与经验现实保持一致 Nader Ebrahimi,Amir Ghaemi The Lancet Infectious Diseases Vol 26(1):e6 15 Artificial intelligence and spillover prediction: aligning innovation with empirical reality in One Health surveillance – Authors' reply 人工智能与溢出预测：在“同一健康”监测中使创新与经验现实保持一致——作者回复 Frank Aarestrup,Marion Koopmans The Lancet Infectious Diseases Vol 26(1):e7 16 Time to tackle vaccine–HLA associations with artificial intelligence 是时候用人工智能解决疫苗-人类白细胞抗原关联问题了 Alexander J Mentzer,George Davey Smith,Teresa Lambe,Julian C Knight,Mary Carrington The Lancet Infectious Diseases Vol 26(1):e8 Corrections（更正） 17 Correction to Lancet Infect Dis 2025; published online Oct 29. 《柳叶刀-传染病》2025年更正；在线发表于10月29日 https://doi.org/10.1016/S1473-3099(25)00466-9 The Lancet Infectious Diseases Vol 26(1):e9 18 Correction to Lancet Infect Dis 2025; published online Oct 27. 《柳叶刀-传染病》2025年更正；在线发表于10月27日 https://doi.org/10.1016/S1473-3099(25)00546-8 The Lancet Infectious Diseases Vol 26(1):e9 19 Correction to Lancet Infect Dis 2025; 25: 1084–96 《柳叶刀-传染病》2025年更正；25卷：1084-1096页 The Lancet Infectious Diseases Vol 26(1):e9 20 Correction to Lancet Infect Dis 2025; published online Nov 10. 《柳叶刀-传染病》2025年更正；在线发表于11月10日 https://doi.org/10.1016/S1473-3099(25)00550-X The Lancet Infectious Diseases Vol 26(1):e9 Newsdesk（新闻台） 21 Highlights of IDWeek 2025 2025年IDWeek亮点 Phoebe Hall The Lancet Infectious Diseases Vol 26(1):e10 22 WHO publishes update on global antibiotic resistance 世界卫生组织发布全球抗生素耐药性最新情况 Timothy Jesudason The Lancet Infectious Diseases Vol 26(1):e11 23 European Commission to fund new medicines for dengue 欧盟委员会资助登革热新药研发 Sanjeet Bagcchi The Lancet Infectious Diseases Vol 26(1):e12 24 Second report from the UK Covid-19 Inquiry 英国新冠肺炎调查第二次报告 Talha Burki The Lancet Infectious Diseases Vol 26(1):e13 25 Infectious disease surveillance update 传染病监测最新情况 Cahal McQuillan The Lancet Infectious Diseases Vol 26(1):e14 26 Research in brief 研究简讯 Priya Venkatesan The Lancet Infectious Diseases Vol 26(1):e15 Obituary（讣告） 27 Jean Louis Abdourahim Ndiaye 让·路易斯·阿卜杜拉希姆·恩迪亚耶 Sanjeet Bagcchi The Lancet Infectious Diseases Vol 26(1):p19 Profile（人物介绍） 28 Fortunate Machingura—tackling climate change and disease 福图纳特·马辛古拉——应对气候变化与疾病 Tony Kirby The Lancet Infectious Diseases Vol 26(1):p20 Media Watch（媒体观察） Book（书籍） 29 The social and political drivers behind pandemics 大流行背后的社会和政治驱动因素 Emma Louise Fabiani The Lancet Infectious Diseases Vol 26(1):p21 Articles（论著） 30 Dynamics of endemic virus re-emergence in children in the USA following the COVID-19 pandemic (2022–23): a prospective, multicentre, longitudinal, immunoepidemiological surveillance study 新冠肺炎疫情后美国儿童地方性病毒重新出现的动态（2022-23年）：一项前瞻性、多中心、纵向、免疫流行病学监测研究 Hai Nguyen-Tran,Sang Woo Park,Matthew R Vogt,Perdita Permaul,Alicen B Spaulding,Michelle L Hernandez,Jennifer A Bohl,Sucheta Godbole,Tracy J Ruckwardt,Peter W Krug,Daniel L Moss,Alexandrine Derrien-Colemyn,Ananda Chowdhury,Gabrielle Dziubla,Lu Wang,Mike Castro,Sandeep R Narpala,Elizabeth R Longtine,Amy R Henry,Teri-T B Ngo,Leonid Dzantiev,George B Sigal,C Jessica Metcalf,David W Kimberlin,Samuel R Dominguez,Abraham Mittelman,Adrian B McDermott,Leonid A Serebryannyy,Bryan Grenfell,Kevin Messacar,Daniel C Douek The Lancet Infectious Diseases Vol 26(1):p22 31 Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial 索托维单抗与常规治疗对住院新冠肺炎患者的疗效对比（RECOVERY）：一项随机、对照、开放标签、平台试验 RECOVERY Collaborative Group RECOVERY协作组 The Lancet Infectious Diseases Vol 26(1):p34 32 A 3-month clofazimine–rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial 含氯法齐明-利福喷丁的3个月方案与标准治疗方案治疗药物敏感性结核病的对比（Clo-Fast）：一项随机、开放标签、2c期临床试验 John Z Metcalfe,Isabelle R Weir,Kimberly K Scarsi,Alberto Mendoza-Ticona,Samuel Pierre,Luke Hall,Jorge Leon-Cruz,Elin M Svensson,Simon E Koele,Wadzanai Samaneka,Cecilia Kanyama,Maxwell Yohane,Neetal Nevrekar,Busisiwe Ntsalaze,Jean Bernard Marc,Melanie Goth,Gary Maartens,Richard Chaissonon behalf of the ACTG A5362 study team The Lancet Infectious Diseases Vol 26(1):p46 33 Global policy responses to antimicrobial resistance, 2021–22: a systematic governance analysis of 161 countries and territories 2021-22年全球应对抗菌药物耐药性的政策反应：对161个国家和地区进行的系统性治理分析 Jay Patel,Sahar Saeedi Moghaddam,Sruthi Ranganathan,Neil Vezeau,Emily O'Neill,Anne Harant,Michael Stolpe,Lothar H Wieler,Tim Eckmanns,Devi Sridhar The Lancet Infectious Diseases Vol 26(1):p55 34 Efficacies of artemether–lumefantrine, artesunate–amodiaquine, dihydroartemisinin–piperaquine, and artesunate–pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial 乌干达6个月至10岁儿童使用蒿甲醚-本芴醇、青蒿琥酯-阿莫地喹、双氢青蒿素-哌喹和青蒿琥酯-吡喃隆治疗无并发症恶性疟原虫疟疾的疗效：一项随机、开放标签、4期临床试验 Moses R Kamya,Joaniter I Nankabirwa,Chris Ebong,Victor Asua,Moses Kiggundu,Stephen Orena,Martin Okitwi,Stephen Tukwasibwe,Bosco Agaba,Daniel Kyabayinze,Jimmy Opigo,Damian Rutazana,Benjamin Binagwa,Edward Mugwanya,Shakira Babirye,Gloria Sebikaari,Patrick M Condo,Grace Appiah,Sam L Nsobya,Melissa D Conrad,Philip J Rosenthal,Leah F Moriarty,Adoke Yeka The Lancet Infectious Diseases Vol 26(1):p67 35 Safety, tolerability, and protective efficacy of a radiation-attenuated, whole sporozoite malaria vaccine in children in Gabon: a randomised, double-blind, placebo-controlled, phase 2 trial 加蓬儿童使用辐射减毒全孢子虫疟疾疫苗的安全性、耐受性和保护效力：一项随机、双盲、安慰剂对照、2期试验 Selidji T Agnandji,Jeroen Bok,Ayodele Alabi,Anita L Kabwende,Armel Mbouna,Juste Bie,Eleonne Moukiti,Albert Lalremruata,Meral Esen,Andrea Kreidenweiss,Natasha KC,B Kim Lee Sim,Thomas L Richie,L W Preston Church,Matthew B B McCall,Stephen L Hoffman,Peter G Kremsner,Benjamin Mordmüller The Lancet Infectious Diseases Vol 26(1):p79 36 Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in São Paulo, Brazil: a test-negative, case–control study TAK-003登革热疫苗在2024年圣保罗暴发期间对青少年的有效性：一项测试阴性病例对照研究 Otavio T Ranzani,Felippe Lazar Neto,Lisany Krug Mareto,Thiago Sanches Brumatti,Roberto Dias de Oliveira,Patricia Vieira da Silva,Edinéia Ribeiro dos Santos,Tatiana Lang D' Agostini,Regiane A Cardoso De Paula,Natalie E Dean,Albert I Ko,Derek A T Cummings,Jason R Andrews,Matt D T Hitchings,Julio Croda The Lancet Infectious Diseases Vol 26(1):p91 37 Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre, randomised, triple-dummy, double-blind, controlled, non-inferiority trial 以利法苏替尼唑为基础的三联疗法与铋剂加克拉霉素为基础的三联疗法作为中国幽门螺杆菌感染一线治疗的对比（EVEREST-HP）：一项3期、多中心、随机、三模拟、双盲、对照、非劣效性试验 Zhiqiang Song,Liya Zhou,Weihong Wang,Cheng Lan,Tongyu Tang,Jun Xie,Huizhen Fan,Xuehong Wang,Xiuli Zuo,Yin Zhu,Chengxia Liu,Yongsong Gu,Huang Feng,Xiang Gao,Qing Zhang,Hong Zhang,Jing Chen,Guozhu Geng,Zhenkun Maon behalf of the EVEREST-HP Study Group The Lancet Infectious Diseases Vol 26(1):p101 Series（专题研讨会） 38 Prevention and Management of Infections in People who are Immunocompromised 免疫功能低下人群感染的预防和治疗 Innovation in active and passive immunisation of people who are immunocompromised: a call to action 免疫功能低下人群主动和被动免疫接种的创新：行动呼吁 Joshua A Hill,Jim Boonyaratanakornkit,Malgorzata Mikulska,Benjamin W Teh,William O Hahn,Ghady Haidar,Catherine Liu,Deepali Kumar,Michael G Ison,Natasha Halasa The Lancet Infectious Diseases Vol 26(1):e16 39 Prevention and Management of Infections in People who are Immunocompromised 免疫功能低下人群感染的预防和治疗 Tackling antimicrobial resistance in people who are immunocompromised: leveraging diagnostic and antimicrobial stewardship 应对免疫功能低下人群的抗菌药物耐药性：利用诊断和抗菌药物管理 Catherine Liu,Emily A Rosen,Erica J Stohs,Hannah Imlay,Masayuki Nigo,Lee S Gottesdiener,Miranda So,Frank Tverdek,Sanjeet Dadwal,Carlota Gudiol,Michael J Satlin,Susan K Seo,Jason A Trubiano,Ritu Banerjee,Kimberly E Hanson,Lilian M Abbo The Lancet Infectious Diseases Vol 26(1):e30 Review（综述） 40 Unveiling the incidences and trends of alveolar echinococcosis in Europe: a systematic review from the KNOW-PATH project 揭示欧洲肺泡棘球蚴病的发病率和趋势：来自KNOW-PATH项目的系统综述 Adriano Casulli,Bernadette Abela,Daniele Petrone,Barbara Šoba,Balázs Dezsényi,Jacek Karamon,Laurence Millon,Urmas Saarma,Daniela Antolová,François Chappuis,Severin Gloor,Marcel Stoeckle,Beat Müllhaupt,Relja Beck,Heimo Lagler,Felix Lötsch,Herbert Auer,Marie-Pierre Hayette,Libuše Kolářová,Sniedze Laivacuma,Mindaugas Šarkūnas,Vitalijus Sokolovas,Audronė Marcinkutė,Karin Troell,Ansgar Deibel,Pikka Jokelainen,Małgorzata Sulima,Dagny Krankowska,Stillhard Roman,Gaëtan-Romain Joliat,Nermin Halkic,Solange Bresson-Hadni,Joanna Halina Bednarek,Andrzej Załęski,Małgorzata Paul,Sheraz Yaqub,Mogens Jensenius,Joke van der Giessen,Laura Nabarro,Peter Chiodini,Florent Demonmerot,Jenny Knapp,Beate Grüner,Peter Kern,Lynn Peters,Federica Santolamazza,Azzurra Santoro The Lancet Infectious Diseases Vol 26(1):e49 Personal View（个人观点） 41 Azithromycin mass drug administration: balancing survival benefits and risks in children 阿奇霉素大规模药物给药：平衡儿童生存益处与风险 Nubwa Medugu,Ian C Michelow,Claudette Poole,Stephen K Obaro The Lancet Infectious Diseases Vol 26(1):e62 Clinical Picture（临床影像） 42 Unexpected finding in a 17-year-old female undergoing screening colonoscopy 17岁女性接受筛查结肠镜检查时的意外发现 Ziheng Calvin Xu,Ethan Tan,Mayur Garg The Lancet Infectious Diseases Vol 26(1):e75 THE LANCET Infectious Diseases. Volume 26Number 2 柳叶刀传染病学 26卷 2期 https://www.thelancet.com/journals/laninf/issue/current EDITORIAL(社论) 1 Call for letters 征稿启事 The Lancet Infectious Diseases The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p111 Comment（述评） 2 Long COVID is here to stay—even in children 长期新冠症状将持续存在——即使在儿童中亦是如此 Danilo Buonsenso The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p112 3 Beyond ritonavir-boosted nirmatrelvir: the case for ensitrelvir in COVID-19 treatment 利托那韦强化版奈玛特韦之外的选择：恩赛特韦在新冠肺炎治疗中的应用 Ming Hong Choi,Ivan Fan Ngai Hung The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p113 4 A new monoclonal in the arMAMentarium against malaria 抗疟“武器库”中的新型单克隆抗体 Freia-Raphaella Lorenz,Matthew B B McCall The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p115 5 Household transmission of mpox in Africa: limited in adults but more prevalent in children 非洲猴痘家庭传播情况：在成人中传播有限，但在儿童中更为普遍 Oriol Mitjà,Michael Marks The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p117 6 The lasting lessons of mpox: infection, vaccination, and immune memory 猴痘带来的持久教训：感染、疫苗接种和免疫记忆 Raianna Fantin,Camila H Coelho The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p118 7 Xpert-Ultra for diagnosing asymptomatic tuberculosis Xpert-Ultra用于诊断无症状结核病 Xia Yu,Hairong Huang The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p120 8 The genomic surveillance gap: averting the antimicrobial resistance pandemic requires global equity and action 基因组监测的差距：避免抗菌药物耐药性大流行需要全球公平与行动 David M Aanensen,Iruka N Okeke,Pilar Donado-Godoy,Beverly Egyir,Ravikumar K Lingegowda,Sonia Siaon behalf of the NIHR Global Health Research Unit on Genomic Surveillance of AMR The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p122 Correspondence（读者来信） 9 Spillover in dengue trials 登革热试验中的溢出效应 Thomas A Smith,Samuel I Watson The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e77 10 Spillover in dengue trials – Author's reply 登革热试验中的溢出效应——作者回复 Fernando Abad-Franch The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e78 11 Updating the traditional voriconazole trough concentration range 传统的伏立康唑谷浓度范围更新 Rongqiang Liao,Xiaoyuan Zheng The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e79 12 Updating the traditional voriconazole trough concentration range – Authors' reply 传统的伏立康唑谷浓度范围更新——作者回复 Inderpaul Singh Sehgal,Ritesh Agarwal,Valliappan Muthu The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e80 13 Clinical course and neurological profile of Kyasanur Forest disease 基萨努尔森林病的临床病程和神经特征 Nitin Gupta,Tirlangi Praveen Kumar The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e82 Corrections（更正） 14 Correction to Lancet Infect Dis 2025; published online Oct 10. https://doi.org/10.1016/S1473-3099(25)00482-7 对《柳叶刀-传染病》2025年发表内容的更正；10月10日在线发表。https://doi.org/10.1016/S1473-3099(25)00482-7 The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e83 15 Correction to Lancet Infect Dis 2025; published online Dec 1. https://doi.org/10.1016/S1473-3099(25)00681-4 对《柳叶刀-传染病》2025年发表内容的更正；12月1日在线发表。https://doi.org/10.1016/S1473-3099(25)00681-4 The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e83 Newsdesk（新闻台） 16 Promising early data for sorfequiline 索氟维林早期数据令人鼓舞 Ed Holt The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e84 17 Highlights from ASTMH 2025 2025年美国热带医学与卫生学会年会亮点 Marco De Ambrogi The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e85 18 Brazil approves domestic single-shot dengue vaccine 巴西批准国产单剂登革热疫苗 Marcia Triunfol The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e86 19 CDC cuts to childhood vaccine recommendations 美国疾控中心削减儿童疫苗接种建议 Priya Venkatesan The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e87 20 WHO launches unified plan for coronaviruses 世界卫生组织启动冠状病毒统一计划 Talha Burki The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e88 21 Infectious disease surveillance update 传染病监测更新 Cahal McQuillan The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e89 22 Research in brief 研究简讯 Priya Venkatesan The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e90 Obituary（讣告） 23 Walter Dowdle 沃尔特·道德尔 Sanjeet Bagcchi The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p124 Profile（人物简介） 24 Katie Anders—improving global dengue control 凯蒂·安德斯——改善全球登革热防控 Tony Kirby The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p125 Media Watch（媒体观察） Film（电影） 25 Eliminating Guinea worm 根除麦地那龙线虫 Sanjeet Bagcchi The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p126 Articles（论著） 26 Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR): a retrospective cohort study 奥密克戎时代儿童与青少年长期新冠症状与SARS-CoV-2再感染的关联（RECOVER-EHR）：一项回顾性队列研究 Bingyu Zhang,Qiong Wu,Ravi Jhaveri,Ting Zhou,Michael J Becich,Yuriy Bisyuk,Frank Blanceró,Elizabeth A Chrischilles,Cynthia H Chuang,Lindsay G Cowell,Daniel Fort,Carol R Horowitz,Susan Kim,Nathalia Ladino,David M Liebovitz,Mei Liu,Abu S M Mosa,Hayden T Schwenk,Srinivasan Suresh,Bradley W Taylor,David A Williams,Jeffrey S Morris,Christopher B Forrest,Yong Chenon behalf of the RECOVER Consortium The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p127 27 Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial 口服恩赛特韦与口服利托那韦强化版奈玛特韦在新冠肺炎治疗中的抗病毒疗效（PLATCOV）：一项开放标签、2期、随机、对照、适应性试验 William H K Schilling,Podjanee Jittamala,Phrutsamon Wongnak,James A Watson,Simon Boyd,Viravarn Luvira,Tanaya Siripoon,Thundon Ngamprasertchai,Elizabeth M Batty,Ellen Beer,Shivani Singh,Tanatchakorn Asawasriworanan,Timothy Seers,Koukeo Phommasone,Terry John Evans,Varaporn Kruabkontho,Thatsanun Ngernseng,Jaruwan Tubprasert,Mohammad Yazid Abdad,Wanassanan Madmanee,Jindarat Kouhathong,Kanokon Suwannasin,Watcharee Pagornrat,Tianrat Piteekan,Borimas Hanboonkunupakarn,Kittiyod Poovorawan,Manus Potaporn,Attasit Srisubat,Bootsakorn Loharjun,Kesinee Chotivanich,Mallika Imwong,Sasithon Pukrittayakamee,Arjen M Dondorp,Nicholas P J Day,Watcharapong Piyaphanee,Weerapong Phumratanaprapin,Nicholas J Whiteon behalf of the PLATCOV Collaborative Group The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p139 28 Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial 头孢地尔与标准疗法治疗医院获得性和医疗保健相关性革兰氏阴性菌血流感染（GAME CHANGER试验）：一项开放标签、平行分组、随机试验 David L Paterson,Helmi Sulaiman,Po-Yu Liu,Mark D Chatfield,Mesut Yilmaz,Zeti Norfidiyati Salmuna,Mohd Zulfakar Mazlan,Siriluck Anunnatsiri,Rujipas Sirijatuphat,Darunee Chotiprasitsakul,David C Lye,Jyoti Somani,Shirin Kalimuddin,Abdullah T Aslan,Visanu Thamlikitkul,Yi-Tzu Lee,Ya-Sung Yang,Yi-Tsung Lin,Wan Nurliyana Wan Ramli,Chien-Hao Tseng,Sophia Archuleta,Yvonne Fu Zi Chan,Brian M Forde,Hugh Wright,Adam G Stewart,Kay A Ramsay,Weiping Ling,Vicki Rossi,Tiffany M Harris-Brown,Patrick N A Harrison behalf of the GAME CHANGER Trial Investigators The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p148 29 Efficacy and safety of ascending doses of orodispersible ivermectin co-administered with albendazole for Trichuris trichiura infections in preschool-aged children in Tanzania: a 坦桑尼亚学龄前儿童感染毛首鞭形线虫时，递增剂量口服分散片伊维菌素与阿苯达唑联合用药的疗效和安全性：一项单盲、随机、对照、剂量递增、2期试验 single-blind, randomised, controlled, dose-ranging, phase 2 trial Viviane P Sprecher,Annina Schnoz,Stefan Biendl,Halima S Hussein,Sarah O Najim,Mohammed N Ali,Ibrahim S Mohammed,Said M Ali,Jan Hattendorf,Jennifer Keiser The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p160 30 Human monoclonal antibody MAM01 for protection against malaria in adults in the USA: a first-in-human, phase 1, dose-escalation, double-blind, placebo-controlled, adaptive trial 人源单克隆抗体MAM01保护美国成年人免受疟疾侵害：一项首次人体、1期、剂量递增、双盲、安慰剂对照、适应性试验 Kirsten E Lyke,Andrea A Berry,Matthew B Laurens,Jennifer Winkler,Sudhaunshu Joshi,Abra Rachida Koudjra,Lauryn Butler,Peter F Billingsley,Tales Pascini,Asha Patil,B Kim Lee Sim,Grace Fitzgerald,Julie Riegel,Kayla Andrews,Micha Levi,Aparna B Anderson,Charles D Wells,Hong Liu,James Huleatt,R Scott Miller The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p170 31 Characterising household transmission dynamics of clade Ib mpox in Burundi: a prospective cohort study 布隆迪Ib分支猴痘家庭传播动力学特征：一项前瞻性队列研究 Raoul Kamadjeu,Ferdinand Nsengimana,Manassé Nimpagaritse,Edna Moturi,Eric Kezakarayagwa,Rose Nkiko,Jonas Ngendakumana,Rémy Nimubona,Liliane Nkengurutse,Hamady Ba,Dionis Nizigiyimana,Paul Ngwakum,Mame Selbee Diouf,France Bégin,Joseph Nyandwi,Douglas James Noble The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p182 32 Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study 比利时猴痘病毒感染或改良痘苗病毒安卡拉株疫苗接种的长期后果（MPX-COHORT和POQS-FU-PLUS）：一项为期24个月的前瞻性和回顾性队列研究 Christophe Van Dijck,Nicole Berens-Riha,Luca M Zaeck,Cécile Kremer,Jacob Verschueren,Jasmine Coppens,Fien Vanroye,Elisabeth Willems,Evi Bosman,Natalie De Cock,Bart Smekens,Leen Vandenhove,Odin Goovaerts,Anke Van Hul,Janne Wouters,Bart K M Jacobs,Stefanie Bracke,Matilde Hens,Isabel Brosius,Elise De Vos,Eugene Bangwen,Sarah Houben,Achilleas Tsoumanis,Pedro Henrique Lopes Ferreira Dantas,Jojanneke Rutgers,Amber Lipman,Koen Wijnans,Patrick Soentjens,Emmanuel Bottieau,Chris Kenyon,Johan van Griensven,Thijs Reyniers,Niels Horst,Kevin K Ariën,Marjan Van Esbroeck,Andrea Torneri,Koen Vercauteren,Wim Adriaensen,Rory D de Vries,Joachim Mariën,Laurens Liesenborghs The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p190 33 Long-term risk of tuberculosis among individuals with Xpert Ultra trace screening results in Uganda: a longitudinal follow-up study 乌干达Xpert Ultra微量筛查结果阳性个体患结核病的长期风险：一项纵向随访研究 Joowhan Sung,Mariam Nantale,Annet Nalutaaya,Patrick Biché,James Mukiibi,Joab Akampurira,Rogers Kiyonga,Francis Kayondo,Michael Mukiibi,Caitlin Visek,Caleb E Kamoga,David W Dowdy,Achilles Katamba,Emily A Kendall The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：p203 Review（综述） 34 Invasive group A streptococcal infections: lessons learned from the 2022–23 upsurge 侵袭性A组链球菌感染：从2022-23年激增中吸取的教训 Alix Flamant,Alicia Demirjian,Theresa Lamagni,Julie Toubiana,Pierre R Smeesters,Jérémie F Cohen The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e91 35 A clinical practice guideline for tuberculous meningitis 结核性脑膜炎临床实践指南 Joseph Donovan,Fiona V Cresswell,Elizabeth W Tucker,Angharad G Davis,Ursula K Rohlwink,Julie Huynh,Regan Solomons,James A Seddon,Nathan C Bahr,Arjan van Laarhoven,Suzanne T Anderson,Sanjay K Jain,Felicia C Chow,Sophie Pattison,James E Scriven,Gabriela Singh,Rob E Aarnoutse,Jan-Willem C Alffenaar,Sofiati Dian,Abi Manesh,Robin Basu Roy,Varinder Singh,Ronald van Toorn,Caryn M Upton,Reinout van Crevel,Kelly E Dooley,Diana Gibb,David Meya,Robert J Wilkinson,Ewelina Rogozińska,Usha K Misra,Anthony Figaji,Guy E Thwaites The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e96 36 Towards shorter therapy for candidaemia: defining uncomplicated candidaemia in adults 缩短念珠菌血症疗程：界定成人非复杂性念珠菌血症 Ilana Reinhold,Susanne Picardi,Blasius Liss,Danila Seidel,Jannik Stemler,Philipp Koehler,Tamara Ruegamer,Rosanne Sprute,Oliver A Cornely The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e112 Personal View（个人观点） 37 A transformation in cholera surveillance 霍乱监测的变革 Amanda K Debes,Erin T Baumgartner,Kendra N Williams,David A Sack The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e124 Clinical Picture（临床图像） 38 Paediatric ocular toxocariasis with relentless progression despite negative metagenomic testing 尽管宏基因组检测呈阴性，但儿科眼弓蛔虫病仍持续进展 Diya Shah,Shiama Balendra,Harry Petrushkin,Anamika Patel The Lancet Infectious Diseases. Feb 2026，Vol 26(2)：e130 THE LANCET Infectious Diseases. Volume 26Number 3 柳叶刀传染病学 26卷 3期 https://www.thelancet.com/journals/laninf/issue/current EDITORIAL（社论） 1 Promises and challenges of AI in infectious diseases 人工智能在传染病领域的承诺与挑战 The Lancet Infectious Diseases The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p213 COMMENT（述评） 2 More real-world evidence for RSV vaccines in the global community 全球范围社区呼吸道合胞病毒（RSV）疫苗的更广泛的现实证据 Kristina L Bajema,Wesley H Self The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p214 3 Rapid diagnostic antigen tests for mpox and the need for decentralised testing—not quite there yet 猴痘快速诊断抗原检测及分散检测的必要性——尚待完善 Daniel Mukadi-Bamuleka,Kevin K Ariën The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p215 4 Solving the data bottleneck for artificial intelligence in infectious diseases 解决传染病人工智能领域的数据瓶颈问题 Cesar de la Fuente-Nunez The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p217 5 Artificial intelligence and One Health: potential for spillover prediction? 人工智能与“同一健康”理念：能否预测病原体外溢？ Marion Koopmans,Istvan Csabai,Daniel Remondini,Emma Snary,Frank Aarestrup The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p219 6 Artificial intelligence in the development of vaccines for infectious diseases 人工智能在传染病疫苗研发中的应用 Steve Black,Shabir A Madhi,Rino Rappuoli The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p221 7 Peer review at The Lancet Infectious Diseases in 2025 2025年《柳叶刀-传染病学》期刊专家评审 Ursula Hofer The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p223 8 Thank you to The Lancet Infectious Diseases statistical and peer reviewers in 2025 感谢2025年《柳叶刀-传染病学》期刊的统计学及评审专家 The Lancet Infectious Diseases Editors The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e132 CORRESPONDENCE（读者来信） 9 Methodological considerations in the attribution of long COVID to first or second infection 首次或二次感染导致长期新冠症状的方法学考量 Sara Carazo,Danuta M Skowronski,Manale Ouakki,Gaston De Serres The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e139 10 Methodological considerations in the attribution of long COVID to first or second infection – Authors' reply 首次或二次感染导致长期新冠症状的方法学考量——作者回复 Bingyu Zhang,Qiong Wu,Ravi Jhaveri,Christopher B Forrest,Yong Chen The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e141 11 Humoral immunity after LP.8.1 monovalent vaccines against a broad range of SARS-CoV-2 variants including XEC, LP.8.1, NB.1.8.1, XFG, and BA.3.2 LP.8.1单价疫苗针对包括XEC、LP.8.1、NB.1.8.1、XFG和BA.3.2在内的多种SARS-CoV-2变异株的体液免疫应答 Yu Kaku,Mizuka Fujiwara,Keiya Uriu,Maximilian Stanley Yo,Shusuke Kawakubo,Jumpei Ito,Naoya Itoh,Yoshifumi Uwamino,Fumitake Saito,Hironori Satoh,The Genotype to Phenotype Japan (G2P-Japan) Consortium,Kei Sato The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e142 12 Precision diagnostics for MBLs: the true game changer in treating antimicrobial resistance 金属β-内酰胺酶精准诊断：治疗抗菌药物耐药性的真正变革者 Brenda A Warecki,María F Mojica,Alejandro J Vila,Robert A Bonomo The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e144 13 Precision diagnostics for MBLs: the true game changer in treating antimicrobial resistance – Authors' reply 金属β-内酰胺酶精准诊断：治疗抗菌药物耐药性的真正变革者——作者回复 David L Paterson,Abdullah T Aslan,Patrick N A Harris The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e145 CORRECTIONS（更正） 14 Correction to Lancet Infect Dis 2025; published online Dec 9. https://doi.org/10.1016/S1473-3099(25)00659-0 《柳叶刀-传染病学》2025年发表文章勘误；在线发表于12月9日。https://doi.org/10.1016/S1473-3099(25)00659-0 The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e146 15 Correction to Lancet Infectious Diseases 2026; published online Jan 20. https://doi.org/10.1016/S1473-3099(25)00773-X 《柳叶刀-传染病学》2026年发表文章勘误；在线发表于1月20日。https://doi.org/10.1016/S1473-3099(25)00773-X The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e146 NEWSDESK（新闻台） 16 Rabies an increasing threat in Ukraine 乌克兰狂犬病威胁日益加剧 Ed Holt The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e147 17 People needing trachoma interventions at record low 需要沙眼干预措施的人数创历史新低 Timothy Jesudason The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e148 18 Uneven STI response in EU/EEA countries 欧盟/欧洲经济区国家性传播感染应对措施不均衡 Sanjeet Bagcchi The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e149 19 Controversial HBV vaccine trial in Guinea-Bissau halted 几内亚比绍有争议的乙型肝炎病毒疫苗试验被叫停 Talha Burki The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e150 20 Research in brief 研究简讯 Priya Venkatesan The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e151 OBITUARY（讣告） 21 Ivan Hirsch 伊万·赫希 Sanjeet Bagcchi The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p224 PROFILE（人物介绍） 22 Reem Abu Shomar— championing water safety in Gaza 里姆·阿布·舒马尔——加沙地带水安全倡导者 Tony Kirby The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p225 MEDIA WATCH（媒体观察） Book（书籍） 23 A prescription for public health literacy 提升公众健康素养的良方 Vijay Shankar Balakrishnan The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p226 Book（书籍） 24 Imagining the inevitable 想象不可避免之事 Cahal McQuillan The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p227 Film（电影） 25 Women's autonomy, safe sex and HIV prevention 女性自主权、安全性行为与艾滋病预防 Sanjeet Bagcchi The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p228 ARTICLES（论著） 26 Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75–79 years in England: a multicentre, test-negative, case–control study 英国75-79岁成年人中双价呼吸道合胞病毒（RSV）预融合F蛋白疫苗对RSV相关住院的有效性：一项多中心、检测阴性、病例对照研究 Rebecca Symes,Heather J Whitaker,Shazaad Ahmad,David Arnold,Suryabrata Banerjee,Cariad M Evans,Robin Gore,Jennifer Hart,Katy Heaney,Onn Min Kon,Anne Melhuish,Munira Ortale Zogaib,Emanuela Pelosi,Najib M Rahman,Gerrit Woltmann,Tricia McKeever,Maria Zambon,Conall H Watson,Wei Shen Lim,Jamie Lopez Bernalon behalf of the HARISS network collaborators The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p229 27 Oral itraconazole versus oral voriconazole for treatment-naive patients with chronic pulmonary aspergillosis in India (VICTOR-CPA trial): a single-centre, open-label, randomised, controlled, superiority trial 印度治疗初治慢性肺曲霉病患者口服伊曲康唑与口服伏立康唑的对比研究（VICTOR-CPA试验）：一项单中心、开放标签、随机、对照、优效性试验 Inderpaul Singh Sehgal,Ritesh Agarwal,Sahajal Dhooria,Kuruswamy Thurai Prasad,Valliappan Muthu,Ashutosh Nath Aggarwal,Shivaprakash M Rudramurthy,Mandeep Garg,Arunaloke Chakrabarti The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p239 28 Accounting for non-adherence to assigned antibiotic treatment duration for bloodstream infection (BALANCE): a post-hoc analysis of a randomised clinical trial 血流感染抗生素治疗疗程依从性考量（BALANCE）：一项随机临床试验的事后分析 Sean W X Ong,Ruxandra Pinto,Robert K Mahar,Asgar Rishu,Joshua S Davis,Robert A Fowler,Steven Y C Tong,Nick Danemanfor the BALANCE trial consortium The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p250 29 Field evaluation of a rapid antigen test for mpox in the Democratic Republic of the Congo and Uganda: a multicentre, prospective, diagnostic accuracy study 刚果民主共和国和乌干达猴痘快速抗原检测的现场评估：一项多中心、前瞻性、诊断准确性研究 Barnabas Bakamutumaho,David Lupande Mwenebitu,Winters Muttamba,Ingrid Ampeire,Henry Kyobe Bosa,Esto Bahizire,Bertin Casinga Bisimwa,Andrew Obuku,Misaki Wayengera,Alison Sandeman,Matthew T G Holden,Patrick D M C Katoto,Bruce Kirenga,Deborah A Williamson,Wilber Sabiiti The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p260 30 Complications and mortality of typhoid fever: an updated global systematic review and meta-analysis 伤寒热的并发症与死亡率：一项更新的全球系统综述与荟萃分析 Shruti Murthy,Nienke N Hagedoorn,Suzanne Faigan,Meera D Rathan,Christian S Marchello,John A Crump The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p270 31 Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 1990-2023年全球、区域和国家层面查加斯病负担：2023年全球疾病负担研究的系统分析 GBD 2023 Chagas Disease and RAISE Study Collaborators The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p284 32 Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial 乌干达健康成年人中ChAdOx1裂谷热疫苗的安全性、耐受性和免疫原性：一项单中心、单盲、随机、安慰剂对照、剂量递增的1期试验 Zacchaeus Anywaine,Jennifer Serwanga,Abu-Baker Mustapher Ggayi,Andrew Max Abaasa,Daniel Wright,Ben Gombe,Peter Ejou,Tamara Namata,Antony Kigozi,Naboth Tukamwesiga,Vincent Basajja,Violet Ankunda,Dora Jocelyn Mulondo,Florence Nambaziira,Ayoub Kakande,Wilson Kakeeto,Phiona Nabaggala,Daniel Jenkin,Alison Lawrie,Pedro Folegatti,Nguyen Tran,Christian Hansen,Alison M Elliott,Adrian V S Hill,George M Warimwe,Pontiano Kaleebu The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p302 33 Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in children, adolescents, and adults in the USA: a randomised, observer-blind, placebo-controlled, phase 2 trial 美国儿童、青少年和成人基础免疫后18个月VLA15莱姆病疫苗候选物的加强免疫接种的免疫原性和安全性：一项随机、观察者盲法、安慰剂对照的2期试验 Laura Wagner,Michaela Obersriebnig,Romana Hochreiter,Vera Kadlecek,Julian Larcher-Senn,Lisa Hegele,Jason D Maguire,Timothy Murphy,Ulla Derhaschnig,Nicole Bézay,Juan Carlos Jaramillo,Susanne Eder-Lingelbach,Marc Messier The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：p314 SERIES（研讨会） Artificial Intelligence and Infectious Diseases 人工智能与传染病 34 Artificial intelligence and infectious diseases: an evidence-driven conceptual framework for research, public health, and clinical practice 人工智能与传染病：基于证据的研究、公共卫生和临床实践概念框架 Anna Odone,Chiara Barbati,Silvia Amadasi,Tanja Schultz,David B Resnik The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e152 35 Artificial intelligence and infectious disease diagnostics: state of the art and future perspectives 人工智能与传染病诊断：现状与未来展望 Luca Miglietta,Timothy M Rawson,Ronald Galiwango,Alex Tasker,Damien K Ming,Darlington Akogo,Cecilia Ferreyra,Eric O Aboagye,N Claire Gordon,Carolina Garcia-Vidal,Jesus Rodriguez-Manzano,Alison H Holmes The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e168 36 Artificial intelligence and infectious diseases: tackling antimicrobial resistance, from personalised care to antibiotic discovery 人工智能与传染病：应对抗菌药物耐药性，从个性化治疗到抗生素发现 Alex Howard,Nada Reza,Peter L Green,Mo Yin,Erin Duffy,Henry C Mwandumba,Alessandro Gerada,William Hope The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e181 REVIEW（综述） 37 Community-acquired respiratory virus infections in patients with haematological malignancies or undergoing haematopoietic cell transplantation: updated recommendations from the 10th European Conference on Infections in Leukaemia 血液系统恶性肿瘤患者或接受造血细胞移植患者社区获得性呼吸道病毒感染：第10届欧洲白血病感染会议更新建议 Marie von Lilienfeld-Toal,Fareed Khawaja,Francesca Compagno,Christine Robin,José-Luis Piñana,Simone Cesaro,Hermann Einsele,Per Ljungman,David Navarro,Michael Boeckh,Roy F Chemaly,Hans H Hirsch The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e193 CLINICAL PICTURE（临床图像） 38 Mycoplasma hominis toe osteomyelitis: a rare and unusual bone infection 人型支原体足趾骨髓炎：一种罕见且不寻常的骨感染 Cheryl Keel,Pauleen McSherry,Rebecca Thombre,Sendurann Nadarajah,Rediat Tewolde,Owen B Spiller,Baharak Afshar The Lancet Infectious Diseases. Mar 2026，Vol 26(3)：e207 THE LANCET Infectious Diseases. Volume 26Number 4 柳叶刀传染病学 26卷 4期 https://www.thelancet.com/journals/laninf/issue/current EDITORIAL(社论) 1 GoGoVax dispels hopes for gonorrhoea vaccination GoGoVax让淋病疫苗的希望破灭 The Lancet Infectious Diseases The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p329 COMMENT（述评） 2 Do the benefits of universal screening outweigh the harms? 全民筛查的益处是否大于害处？ Alanna N Gillespie,Emma Webb,Valerie Sung The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p330 3 Chikungunya in Brazil: vaccination strategies informed by mathematical modelling 巴西基孔肯雅热：基于数学建模的疫苗接种策略 José Lourenço,Marta Giovanetti The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p331 4 Chikungunya adolescent vaccination and the distinct risk–benefit landscapes 青少年接种基孔肯雅热疫苗及独特的风险-获益情况 Ernesto T A Marques,Simon Barratt-Boyes The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p333 5 Circulation of clade Ib mpox outside of Africa—are we prepared? 非洲以外地区Ib分支猴痘的传播——我们准备好了吗？ Seth D Judson,Claude Kwe Yinda,Franziska K Kaiser,Daniel S Chertow,Emmie de Wit,James O Lloyd-Smith,Vincent J Munster The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p334 6 I worked at WHO: the USA leaving will not make America healthier 我曾在世卫组织工作：美国退出不会让美国更健康 Krutika Kuppalli The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p336 CORRESPONDENCE（读者来信） 7 Maternal views on RSV vaccination in the UK's second season 英国第二季呼吸道合胞病毒疫苗接种的产妇观点 Shaun O'Hagan,Steve Cunningham,Simon B Drysdale,Helen E Groves,Samantha Hunt,Dalia Iskander,Xinxue Liu,Mark D Lyttle,Chengetai D Mpamhanga,Thomas Waterfield,Thomas C Williams,Robin Marlow,Damian Rolandon behalf of the PERUKI & BronchStart/Stop Collaboration The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e209 8 Overcoming immune imprinting with the COVID-19 LP.8.1 mRNA boosters 利用COVID-19 LP.8.1 mRNA加强针克服免疫印记 Ninaad Lasrado,Annika Rössler,Katherine Molloy,Isabella McConnell,Ritobhas Bhowmik,Francisco Armando Granados-Contreras,Jessica Wu,Alejandra Waller-Pulido,Samuel J Nangle,Erica Borducchi,Ai-ris Y Collier,Dan H Barouch The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e212 CORRECTIONS（更正） 9 Correction to Lancet Infect Dis 2025; published online Nov 27.  https://doi.org/10.1016/S1473-3099(25)00605-X 《柳叶刀-传染病学》2025年刊载内容更正；在线发布于11月27日 The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e214 10 Correction to Lancet Infect Dis 2026; 26: 343–61 《柳叶刀-传染病学》2026年刊载内容更正；26卷：343-61页 The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e214 11 Correction to Lancet Infect Dis 2026; published online Jan 23. https://doi.org/10.1016/S1473-3099(25)00730-3 《柳叶刀-传染病学》2026年刊载内容更正；在线发布于1月23日 The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e214 12 Correction to Lancet Infect Dis 2026; published online Jan 28. https://doi.org/10.1016/S1473-3099(25)00747-9 《柳叶刀-传染病学》2026年刊载内容更正；在线发布于1月28日 The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e214 NEWSDESK（新闻台） 13 UK loses measles elimination status as cases rise 随着病例增加，英国失去麻疹消除地位 Priya Venkatesan The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e215 14 Brazil launches implementation study of lenacapavir 巴西启动来那卡帕韦实施研究 Tony Kirby The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e216 15 Clade Ib mpox in southwest Indian Ocean islands 西南印度洋岛屿出现Ib分支猴痘 Esther Nakkazi The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e217 16 EMA approves combined COVID-19 and flu mRNA vaccine 欧洲药品管理局批准COVID-19和流感联合mRNA疫苗 Talha Burki The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e218 17 Research in brief 研究简讯 Priya Venkatesan The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e219 OBITUARY（讣告） 18 Nicholas John White 尼古拉斯·约翰·怀特 Sanjeet Bagcchi The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p339 PROFILE（人物简介） 19 Katharina Kranzer—led by curiosity, committed to capacity 卡塔琳娜·克兰泽——受好奇心驱使，致力于提升能力 Tony Kirby The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p340 MEDIA WATCH（媒体观察） Film（电影） 20 Leishmaniasis: a story of two continents 利什曼病：两个大陆的故事 Vijay Shankar Balakrishnan The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p341 Book（书籍） 21 Finding your voice in a world of uncertainty 在不确定的世界中找到自己的声音 Carrie Fielden The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p342 ARTICLES（论著） 22 Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 1990-2023年下呼吸道感染的全球负担及病因：2023年全球疾病负担研究的系统分析 GBD 2023 Lower Respiratory Infections and Antimicrobial Resistance Collaborators GBD 2023下呼吸道感染和抗菌素耐药性协作组 The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p343 23 Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis 英国苏格兰地区母体RSVpreF疫苗对婴儿严重疾病的保护效果：一项全国性、基于人群的病例对照研究和队列分析 Isobel McLachlan,Chris Robertson,Kirsty E Morrison,Ross McQueenie,Safraj Shahul Hameed,Cheryl Gibbons,Rachael Wood,Rachel Merrick,Louisa Pollock,Antonia Ho,Ting Shi,Thomas C Williams,Sir Aziz Sheikh,Jim McMenamin,Sam Ghebrehewet,Kimberly Marsh The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p362 24 Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort study 法国儿童COVID-19后支原体肺炎感染的复现（ORIGAMI）：一项回顾性和前瞻性多中心队列研究 Anaïs Chosidow,Zoha Maakaroun-Vermesse,Vichita Ok,Cécile Delecroix,Pascal Le Roux,Marie-Aliette Dommergues,Justine de Larminat,Eric Jeziorski,Pauline Ronjat,Léa Jaume,Anne Welfringer-Morin,Cécile Bébéar,Maud Gits-Muselli,Delphine Viriot,Charles-Joris Roux,Stéphane Bechet,Anne-Sophie Romain,Mathie Lorrot,Robert Cohen,Corinne Levy,Jérémie F Cohenon behalf of the ORIGAMI Study Group The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p374 25 Lessons derived from a 3-year congenital cytomegalovirus screening programme in Israel: a prospective population-based cohort study 以色列先天性巨细胞病毒筛查项目的3年经验教训：一项前瞻性基于人群的队列研究 Smadar Eventov Friedman,Noa Ofek Shlomai,Esther Oiknine-Djian,Tal Sido,Oren Gordon,Sraya Greenberger,Hadar Horowitz,Lior Merav,Stav David Mehaber,Orit Caplan,Miriam Geal-Dor,Natalia Simanovsky,Diana Averbuch,Colin Kunzweiler,Yosefa Hefter,John Diaz-Decaro,Ora Paltiel,Moran Yassour,Dana G Wolf The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p384 26 Comparison of the performance and costs of testing algorithms using rapid diagnostic tests for detection and treatment of syphilis among pregnant individuals and men who have sex with men: a modelling study 使用快速诊断检测方法对孕妇和男男性行为者进行梅毒检测和治疗的不同检测算法的性能和成本比较：一项建模研究 Ying Zhang,Eric P F Chow,Lei Zhang,Christopher K Fairley,Jason J Ong The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p394 27 The epidemiology of chikungunya virus in Brazil and the potential impact of vaccines: a mathematical modelling study 巴西基孔肯雅热病毒的流行病学及疫苗的潜在影响：一项数学建模研究 Oscar Cortes-Azuero,Megan O'Driscoll,Gabriel Ribeiro dos Santos,Ronaldo de Jesus,Shirlene T S de Lima,Danny Scarponi,Christinah Mukandavire,Arminder Deol,Moritz U G Kraemer,William M de Souza,Henrik Salje The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p406 28 Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in adolescents: final results from a 12-month, double-blind, randomised, placebo-controlled, phase 3 trial in endemic areas of Brazil 青少年接种减毒活基孔肯雅热病毒疫苗的安全性和免疫原性：巴西流行地区一项为期12个月、双盲、随机、安慰剂对照的3期试验最终结果 Vera Buerger,Andrea Pfeiffer,Petra Schoengrundner,Jutta Seebacher,Romana Hochreiter,Karin Kosulin,Oliver Zoihsl,Petronela Weisova,Robert Mader,Ana Paula Loch,Eolo Morandi Jr,Mauricio Lacerda Nogueira,Carlos Alexandre Antunes de Brito,Julio Croda,Mauro Martins Teixeira,Ivo Castelo-Branco Coelho,Ricardo Gurgel,Allex Jardim da Fonseca,Marcus Vinícius Guimarães de Lacerda,Edson Duarte Moreira Jr,Ana Paula Rocha Veiga,Susanne Eder-Lingelbach,Juan Carlos Jaramillo The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p417 29 National burden of and optimal vaccine policy for Japanese encephalitis virus in Bangladesh: a seroprevalence and modelling study 孟加拉国日本脑炎病毒的全国负担及最佳疫苗接种政策：一项血清流行率和建模研究 Mariana Perez Duque,Kishor K Paul,Rebeca Sultana,Gabriel Ribeiro dos Santos,Megan O'Driscoll,Abu M Naser,Mahmudur Rahman,Mohammad Shafiul Alam,Hasan M Al-Amin,Mohammed Z Rahman,Mohammad E Hossain,Repon C Paul,Elias Krainski,Stephen P Luby,Simon Cauchemez,Jessica Vanhomwegen,Emily S Gurley,Henrik Salje The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：p429 REVIEW（综述） 30 Autoantibodies in long COVID: a systematic review 长新冠中的自身抗体：一项系统综述 Fabian Wilhelm,Janne Cadamuro,Sylvia Mink The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e220 31 Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE) 登革热临床试验核心结局测量指标集：一项国际德尔菲共识研究（DEN-CORE） Sophie Yacoub,Anastasia Demidova,Xin Hui S Chan,Ali Ajam,Dina Baimukhambetova,Andreij Horn,Evgeniia Kakotkina,Mark Kosenko,Aigun Mursalova,Jennifer Ilo Van Nuil,Chi Le Phuong,Lin Xiao,Sudeep Adhikari,Juan David Alzate Alvarez,Kathryn B Anderson,Panisadee Avirutnan,Stephanie Buchholz,Richa Chandra,Aileen Y Chang,Ho Quang Chanh,Mónika Patricia Consuegra Rodríguez,Vanessa Daniel,Janet V Diaz,Claudia Figueiredo-Mello,Rosa Margarita Gelvez-Ramírez,Tran Bang Huyen,Evelyne Kestelyn,Phung Khanh Lam,Stije J Leopold,Ruobing Li,Tran Luu,David Chien Boon Lye,Angela McBride,Isabelle Meyer-Andrieux,Nathaniel J Moorman,Nguyet Minh Nguyen,Sharifah Faridah Syed Omar,Hang Cheng Ong,Eng Eong Ooi,Ekaterina Pazukhina,Sarah L Pett,Diego Bastos Porto,Giri S Rajahram,Marc Rogers,Elsa Rojas,James Rosen,Jamie Rylance,William H K Schilling,Andre M Siqueira,Peter Sjö,Alfonso Sucerquia-Hernandez,Dong Thi Hoai Tam,Mauro Martins Teixeira,Andreas Tietz,Huynh Trung Trieu,Annalise Unsworth,Luis Villar,Adam Tully Waickman,James A Watson,Bridget A Wills,Po Ying Chia,Patricia Brasil,Thomas Jaenisch,Lucy Lum,Gathsaurie Neelika Malavige,Steven McGloughlin,Bharath Kumar Tirupakuzhi Vijayaraghavan,Laura Merson,Daniel Munblitthe DEN-CORE Study Group The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e231 PERSONAL VIEW（个人观点） 32 Breaking the under-reporting cycle for zoonotic diseases in low-income and middle-income countries through national-level integration of community-based surveillance and response: insights from Cameroon, Chad, Côte d’Ivoire, and Mali 通过国家层面整合社区监测和响应，打破低收入和中等收入国家人畜共患病报告不足的循环：来自喀麦隆、乍得、科特迪瓦和马里的见解 Katherine E L Worsley-Tonks,Mahamat Fayiz Abakar,Zanan Coulibaly,Marie Paulette Deya-Yang,Linda Esso,Jean Marc Kameni Feussom,Vessaly Kallo,Zakaria Keita,Monique Lechenne,Magloire Tchamba Kombou,Inès Emah Manda,Christiane Mangou,Stephanie Mauti,Aime Gilert Mbonda Noula,Rodrigue Poueme Namegni,Perrine Parize,Mathurin Cyrille Tejiokem,Isaac Tiembre,Abdallah Traoré,Jakob Zinsstag,Hervé Bourhy The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e245 GRAND ROUND（大查房） 33 Paediatric case of invasive group A streptococcal necrotising myositis: diagnostic challenges and lessons learned 儿童侵袭性A组链球菌坏死性肌炎病例：诊断挑战和经验教训 Suraya Yusuf,Michael James Carter,Jenny Woodruff,Peter Kalu,Justin Conrad Rosen Wormald,Claire Sethu The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e259 CLINICAL PICTURE（临床图像） 34 Bullous haemorrhagic cellulitis caused by Escherichia coli in a patient with cirrhosis 肝硬化患者由大肠杆菌引起的大疱性出血性蜂窝织炎 Irene Rivera-Ruiz,Paloma Elma Alañón-Martínez,Elisa Vidal-Verdú The Lancet Infectious Diseases. Apr 2026，Vol 26(4)：e268 THE LANCET Infectious Diseases. Volume 26Number 5 柳叶刀·传染病学26卷 5期 https://www.thelancet.com/journals/laninf/issue/current EDITORIAL(社论) 1 How are vaccine recommendations made? 疫苗建议是如何制定的？ The Lancet Infectious Diseases The Lancet Infectious Diseases. May 2026，Vol 26(5)：p439 COMMENT（述评） 2 First efficacy evidence for a multistage malaria vaccine targeting infection and transmission 针对感染和传播多阶段的疟疾疫苗首次显示出有效性证据 Gemma Moncunill,Carlota Dobaño The Lancet Infectious Diseases. May 2026，Vol 26(5)：p440 3 Lassa viral dynamics: implications for missed diagnosis 拉沙病毒动态：对漏诊的影响 Chinwe Lucia Ochu,William Douglas Evans The Lancet Infectious Diseases. May 2026，Vol 26(5)：p441 4 Nirsevimab over two RSV seasons: do the findings align with expectations? 两个呼吸道合胞病毒（RSV）季节中Nirsevimab的应用情况：研究结果是否符合预期？ Corinne Levy,Robert Cohen The Lancet Infectious Diseases. May 2026，Vol 26(5)：p443 5 Improving antimalarial therapeutic efficacy studies 提高抗疟治疗疗效研究的质量 Philip J Rosenthal The Lancet Infectious Diseases. May 2026，Vol 26(5)：p444 6 The case for routine patient review in long COVID research 在长期新冠研究中开展常规患者评估的理由 Letícia Soares,C H Romatowski,Gina Assaf,Chloé de Canson The Lancet Infectious Diseases. May 2026，Vol 26(5)：p446 CORRESPONDENCE（读者来信） 7 When mpox is not mpox: varicella and measles in DR Congo 当猴痘并非猴痘时：刚果民主共和国的水痘和麻疹病例 Levi Bugwaja,Nathan Banzi,Trust Faraja Mukika,Patrick Kazuba Bugale,Patrick Musole Bugeme,Emmanuel Biragi Nzenze,Heshima Lajeri Nzirimo,Salomon Mashupe Shangula,Justin Bengehya,Willy Kasi,Krutika Kuppalli,Camille Escadafal,Daniel Mukadi-Bamuleka,Jackie Knee,Jules Jackson,Elizabeth C Lee,Andrew S Azman,Espoir Bwenge Malembaka The Lancet Infectious Diseases. May 2026，Vol 26(5)：e209 8 Mpox virus in human breastmilk and tecovirimat pharmacokinetics: implications for postnatal transmission 人乳中的猴痘病毒及特考韦瑞药代动力学：对产后传播的影响 Francesca Colavita,Massimo Tempestilli,Silvia Meschi,Carla Pittini,Martina Rueca,Giuseppe Sberna,Fabrizio Carletti,Simone Lanini,Silvia Cammisa,Giulia Paviotti,Lorenza Driul,Miriam De Vito,Cesare Ernesto Maria Gruber,Marco Cotrufo,Eleonora Cimini,Valentina Mazzotta,Andrea Antinori,Carlo Tascini,Fabrizio Maggi,Licia Bordi The Lancet Infectious Diseases. May 2026，Vol 26(5)：e211 CORRECTIONS（更正） 9 Correction to Lancet Infect Dis 2026; 26: 522–34 对《柳叶刀-传染病》2026年第26卷第522–34页的更正 The Lancet Infectious Diseases. May 2026，Vol 26(5)：e213 NEWSDESK（新闻台） 10 New WHO recommendations for tuberculosis diagnosis 世卫组织新的结核病诊断建议 Timothy Jesudason The Lancet Infectious Diseases. May 2026，Vol 26(5)：e214 11 New report assesses antimicrobial pipeline 新报告评估抗菌药物研发管线 Manjulika Das The Lancet Infectious Diseases. May 2026，Vol 26(5)：e215 12 Meningitis B outbreak in England 英格兰B型脑膜炎暴发 Tony Kirby The Lancet Infectious Diseases. May 2026，Vol 26(5)：e216 13 WHO reports on health of migrants and refugees 世卫组织发布移民和难民健康报告 Talha Burki The Lancet Infectious Diseases. May 2026，Vol 26(5)：e217 14 Research in brief 研究简讯 Priya Venkatesan The Lancet Infectious Diseases. May 2026，Vol 26(5)：e218 OBITUARY（讣告） 15 Christian C Patrick 克里斯蒂安·C·帕特里克 Sanjeet Bagcchi The Lancet Infectious Diseases. May 2026，Vol 26(5)：p448 PROFILE（人物简介） 16 Eizo Takashima—developing a new class of malaria vaccines 高石荣三——开发新型疟疾疫苗 Tony Kirby The Lancet Infectious Diseases. May 2026，Vol 26(5)：p449 MEDIA WATCH（媒体观察） Book（书籍） 17 Feminism and the AIDS epidemic 女权主义与艾滋病流行 Charlotte Day The Lancet Infectious Diseases. May 2026，Vol 26(5)：p450 ARTICLES（论著） 18 Efficacy of ProC6C-AlOH/Matrix-M against Plasmodium falciparum infection and mosquito transmission: a phase 2, randomised, controlled human malaria infection study ProC6C-AlOH/Matrix-M预防恶性疟原虫感染和蚊子传播的有效性：一项2期随机对照人体疟疾感染研究 Mamady Kone,Jordan Plieskatt,Moussa Thienta,Bourama Kamate,Ebenezer A Ofori,Markus Gmeiner,Bayaya Haidara,Moussa B Kanoute,Bakary Traore,Ousmane A Poudiouguo,Hawa S Bayogo,Ibrahim Diarra,Karim Bengaly,Amatigue Zeguime,Daman Sylla,Adama Sacko,Stephen L Hoffman,Matthew B B McCall,Michael Theisen,Issaka Sagaraon behalf of the ProC6C Study Group The Lancet Infectious Diseases. May 2026，Vol 26(5)：p451 19 The effectiveness of long-lasting spatial repellent emanators against malaria in humanitarian crisis settings in northern Nigeria: a two-arm pragmatic, open-label, controlled trial 长效空间驱蚊剂在尼日利亚北部人道主义危机环境中预防疟疾的有效性：一项双臂实用、开放标签、对照试验 Richard James Allan,Ramona Scherrer,Sara Estecha-Querol,David Weetman,Laura Paris,Umar Ba'abba Goni,Fatima Idris Abdulhamid,Blaise Nfornuh Alenwi,Sajjad Ahmad,Chad L Cross,Garba Mohammed Ashir,Mala Waziri,Godwin Ntadom,Louisa Alexandra Messenger The Lancet Infectious Diseases. May 2026，Vol 26(5)：p464 20 Lassa fever symptomatology, viral dynamics, and host immune response (PREPARE): a prospective, observational cohort study in Liberia 拉沙热症状、病毒动态和宿主免疫反应（PREPARE）：利比里亚一项前瞻性观察队列研究 David A Wohl,Carwolo Pewu,Chanhwa Lee,Emmanuel Kerkula,Martha Gayflowu,Nukal Doetein,Katie R Mollan,Taylor J Krajewski,Becky Straub,Alfred Flomo,Amara Fofana,Stanley Kerkula,Thomas Sumo,Alexander Sampson,Samuel Vouh,Fred Flomo,McKenzie A Colt,Thomas Remont,Eleanor Rose Watts,Marta Zizek,Catherine Nimely,Minnie Ricks,Jefferson Sibley,William A Fischer II The Lancet Infectious Diseases. May 2026，Vol 26(5)：p475 21 Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled study B群链球菌疫苗（GBS-AlpN）在孕妇及其婴儿中的免疫原性和安全性：一项2期、多中心、观察者设盲、随机、安慰剂对照研究 Paul T Heath,Ntokozo Zuma-Gwala,Rikke Bek Helmig,Elizea Horne,Anette Kjærbye-Thygesen,Mie Korslund Wiinblad Crusell,Maphoshane Nchabeleng,Renate Strehlau,Mohammed R Khalil,Christine E Jones,Jorne Biccler,Jeannett Dimsits,Bengt Johansson-Lindbom,Per B Fischer,Lidia Oostvogels,Shabir A Madhion behalf of the MVX0004 study group The Lancet Infectious Diseases. May 2026，Vol 26(5)：p486 22 Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trial 单剂量口服减毒霍乱活疫苗PanChol的安全性和免疫原性：一项1a期、双盲、随机、安慰剂对照试验结果 Deborah R Leitner,Stephen R Walsh,Masataka Suzuki,Michaël Desjardins,Alisse Hannaford,Amy C Sherman,Hannah Levine,Lena Carr,Elliot Hammerness,Akina Osaki,Emily Sullivan,Bryan Wang,George I Balazs,Jun Bai Park Chang,Damien M Slater,Nirajan Puri,Carole J Kuehl,Wilbur H Chen,Jason B Harris,Steven Piantadosi,Lindsey R Baden,Matthew K Waldoron behalf of the PanChol study group The Lancet Infectious Diseases. May 2026，Vol 26(5)：p497 23 Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial 晚期艾滋病患者使用整合酶抑制剂与蛋白酶抑制剂治疗（LAPTOP）：一项多国、随机、开放标签、非劣效性试验 Georg M N Behrens,Lambert Assoumou,Geoffroy Liegeon,Andrea Antinori,Rafael Micán,Francesco G Genderini,Frank A Post,Jürgen K Rockstroh,Lisa Hamzah,Pere Domingo,Adrian Curran,Montserrat Laguno,Carl Fletcher,Jack Moody,Anton Pozniakon behalf of the NEAT-ID Foundation,and LAPTOP Study Team The Lancet Infectious Diseases. May 2026，Vol 26(5)：p510 24 Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study 在西班牙加利西亚婴儿中进行Nirsevimab普遍预防，对横跨两个呼吸道合胞病毒季节的医院和初级保健结果的影响（NIRSE-GAL）：一项基于人群的前瞻性观察研究 Josefina L Razzini,Iago Giné-Vázquez,Jing Jin,María-Isolina Santiago-Pérez,Olaia Pérez-Martínez,María-Teresa Otero-Barrós,Nuria Suárez-Gaiche,Rolf Kramer,Leticia Platero-Alonso,Rosa-María Álvarez-Gil,Olga-María Ces-Ozores,Victoria Nartallo-Penas,Susana Mirás-Carballal,Marta Piñeiro-Sotelo,Juan-Manuel González-Pérez,Carmen Rodríguez-Tenreiro-Sánchez,Ángela Manzanares-Casteleiro,Ana Dacosta-Urbieta,Cintia Álvarez-Smith,Irene Rivero-Calle,Antonio Salas,Carmen Durán-Parrondo,Narmeen Mallah,Federico Martinón-Torres The Lancet Infectious Diseases. May 2026，Vol 26(5)：p522 25 Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled study CRS3123治疗成人艰难梭菌感染初次发作或首次复发的安全性和有效性：一项2期、随机、双盲、多中心、万古霉素对照研究 Thomas Louie,Wendy Ribble,Louis Boccumini,Katherine Johnson,Mary A De Groote,Joshua Day,Clifford Mason,Xicheng Sun,Jane Freeman,Kenan Gu,Glenn Tillotson,Mark H Wilcox,Nebojsa Janjic,Thale C Jarvis,Seema U Nayak,Urs A Ochsner,Jon B Bruss The Lancet Infectious Diseases. May 2026，Vol 26(5)：p535 REVIEW（综述） 26 The Emerging Resistance Index: tracking early resistance to new antibiotics 新兴耐药指数：追踪新抗生素的早期耐药性 Jacopo Garlasco,Fabiana Arieti,Matteo Morra,Maela Tebon,Diego Ortiz,Maria Diletta Pezzani,Karin Odoj,Federica Manco,Alessandro Cassini,Stephan Harbarth,Elisabeth Presterl,Biljana Carevic,Gunnar Kahlmeter,Karin Thursky,Paola Morelli,Stefan Hagel,Alessia Savoldi,Evelina Tacconelli The Lancet Infectious Diseases. May 2026，Vol 26(5)：e219 27 Kyasanur Forest disease: an emerging arboviral threat 基萨努尔森林病：一种新兴的虫媒病毒威胁 Neha Pandey,Sunit K Singh The Lancet Infectious Diseases. May 2026，Vol 26(5)：e228 PERSONAL VIEW（个人观点） 28 Reconsidering the clinical assessment of resistance to slowly eliminated antimalarial drugs in high-transmission settings 重新考虑高传播地区对缓慢消除抗疟药物耐药性的临床评估 Nicholas J White,James A Watson The Lancet Infectious Diseases. May 2026，Vol 26(5)：e240 GRAND ROUND（大查房） 29 Safe delivery of intensive care for Marburg virus disease in Rwanda 卢旺达安全实施马尔堡病毒病重症监护 Eric Seruyange,Ernest Nahayo,François Xavier Uwimana,Joseph Biramahire,Fidele Hakorimana,Menelas Nkeshimana,David Turatsinze,Anselme Bizimana,Hassan Mugabo,Bosco Burakari,Ryan P Westergaard,Louise Mwiseneza,Nicholas Niyigaba,Jean Pierre Sibomana,Tsion Firew,Lambert Ingabire,Gaston Nyirigira,Etienne Kayigi,Evariste Mushuru,Marie Grace Niwemuhoza,Marie Grace Niyonizeye,Gisele Isingizwe,Josué Bongwa Rwibutso,Jean Pierre Nzabana,Gentil Semahoro Ndayishimiye,Déo Kimalarungu Ntakambirwa,Serge Kazindu,Halifa Ndayisabye,Eric Remera,Leon Mutesa,Jean Paul Rwabihama,Muhammed Semakula,Robert Fowler,Ruggero Giuliani,Jacob Goldberg,Frederique Jacquerioz,Janet Diaz,Amanda Rojek,Claude M Mambo,Yvan Butera,Sabin Nsanzimana,Elizabeth O Moreton,Thomas E Fletcher,William A Fischer 2nd,Théogène Twagirumugabe The Lancet Infectious Diseases. May 2026，Vol 26(5)：e248 CLINICAL PICTURE（临床图像） 30 Disseminated fusariosis arising from onychomycosis in a haematopoietic transplant recipient 造血干细胞移植受者甲癣引发的播散性镰刀菌病 Wouter A A de Steenhuijsen Piters,Man Wai Tang,Inge A H van den Berk,M E Baarsma,Karin van Dijk The Lancet Infectious Diseases. May 2026，Vol 26(5)：e256 THE LANCET Infectious Diseases. Volume 26Number 6 柳叶刀·传染病学26卷 6期 https://www.thelancet.com/journals/laninf/issue/current Editorial（社论） 1 The value of infectious disease conferences 传染病会议的价值 The Lancet Infectious Diseases The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p549 Comment（述评） 2 From emergency to integration: research as the bridge in mpox control 从紧急应对到整合：作为猴痘防控的桥梁的研究 Yap Boum,Mosoka Fallah,Michel Muteba,Henry Kyobe Bosa,Kyeng Mercy,John Misaki Wayengera,Bruce Kirenga,John Otshudiema,Placide Mbala,Marie-Roseline Belizaire,Ngashi Ngongo,Jean Kaseya The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p550 3 Strength of ATLAS or lady luck in a sepsis management trial? 脓毒症治疗试验，是ATLAS的力量还是幸运女神的眷顾？ Mojdeh Azimi,Dick Menzies The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p552 4 Reimagining radical cure for Plasmodium vivax 重新构思间日疟原虫的根治方案 Pyae Linn Aung,Liwang Cui The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p554 5 Does BA.3.2 epidemiology imply a change in SARS-CoV-2 evolution? BA.3.2的流行病学是否意味着SARS-CoV-2进化方向的改变？ Lu Zhang,Markus Hoffmann,Stefan Pöhlmann The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p555 Correspondence（读者来信） 6 Concerns regarding study of spatial emanators for malaria control 关于研究用于疟疾防控的空间传播因子的担忧 John Bradley,Richard Hayes,Peter G Smith,Immo Kleinschmidt The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e209 7 Concerns regarding study of spatial emanators for malaria control – Authors' reply 关于疟疾防控中空间散发器研究的关切——作者回复 Richard James Allan,Chad L Cross,Louisa Alexandra Messenger The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e210 Newsdesk（新闻台） 8 Bangladesh launches measles vaccine drive amid outbreak 孟加拉国在疫情期间启动麻疹疫苗接种运动 Samaan Lateef The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e211 9 Tecovirimat no longer approved for mpox in the EU 欧盟不再批准替可韦利马用于猴痘治疗 Sanjeet Bagcchi The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e212 10 Highlights of ESCMID Global 2026 2026年ESCMID全球大会亮点 Syeda Saleha Hassan The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e213 11 Global vaccination drive reaches 18.3 million children 全球疫苗接种运动已覆盖1830万儿童 Timothy Jesudason The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e214 12 Israel accused of using “water as a weapon” in Gaza 以色列被指控在加沙"以水为武器" Talha Burki The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e215 13 Research in brief 研究简报 Priya Venkatesan The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e216 Obituary（讣告） 14 James Phillip Luby 詹姆斯·菲利普·卢比 Sanjeet Bagcchi The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p558 Profile（人物介绍） 15 Daniela Hozbor—raising the bar for pertussis vaccines 丹妮拉·霍兹博尔——提升百日咳疫苗标准 Tony Kirby The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p559 Media Watch（媒体观察） Book（书籍） 16 Building bridges 搭建桥梁 Hollie Sherwood-Martin The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p560 Articles（论著） 17 Safety of MVA-BN vaccine in health-care personnel in DR Congo: a prospective cohort study MVA-BN疫苗在刚果（金）医务人员中的安全性：前瞻性队列研究 Faisal S Minhaj,Anna Mandra,Béatrice U Nguete,Toutou Likafi,Gaston Kokola,Stephanie Tran,Jordan L Kennedy,Benjamin Monroe,Christine M Hughes,Taina Joseph,Marissa K Person,Michael B Townsend,Panayampalli S Satheshkumar,Joelle Kabamba,Mary G Reynolds,Agam K Rao,Dorah Kasongo,Patricia A Yu,Yon Yu,Robert Shongo Lushima,Didine Kaba,Brett Petersen,Andrea M McCollum The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p561 18 Immunogenicity and safety of MVA-BN vaccine administered 5 years after a two-dose primary series in DR Congo: a prospective cohort study 两剂基础免疫后5年接种MVA-BN疫苗的免疫原性和安全性：刚果（金）前瞻性队列研究 Lalita Priyamvada,Faisal S Minhaj,Toutou Likafi,Elisabeth Pukuta,Elisabeth Muyamuna,William C Carson,Margaret Moriarty,Sergio Rodriguez,Taina Joseph,Joelle Kabamba,Gaston Kokola,Robert Shongo Lushima,Jean-Jacques Muyembe-Tamfum,Christine M Hughes,Brett W Petersen,Yon Yu,Agam Rao,Andrea M McCollum,Didine K Kaba,Beatrice U Nguete,Panayampalli S Satheshkumar,Michael B Townsend The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p571 19 A combined ELISA for infection-induced and vaccine-induced mpox antibodies during the clade Ib outbreak in Rwanda: an observational, cross-sectional, clinical validation study 伊布分支疫情期间卢旺达猴痘感染诱导和疫苗诱导抗体联合ELISA检测：观察性横断面临床验证研究 Jenny Clarke,Herve Semukunzi,Sian E Faustini,Jennifer L J Heaney,Hin Fai Kwok,Jean Marie Vianney Uwimana,Karishma Gokani,Gilbert Rukundo,Jean Pierre Musabyimana,Prosper Ingabire,Leopold Bitunguhari,Jean de Dieu Harelimana,Alex G Richter,Claude M Muvunyi,Christopher A Greenand the MpoxCARE Study Team The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p581 20 Case presentation of patients hospitalised with mpox (subclade Ib/2023sh) including children, adolescents, and adults in South Kivu, Democratic Republic of the Congo: an observational cohort study 刚果（金）南基伍省住院猴痘患者（伊布亚分支/2023sh）病例报告，包括儿童、青少年和成人：观察性队列研究 Luis Flores Girón,Gustavo Sganzerla Martinez,Baganda Ntahuma Daniel,Alfred Kesheni Bisimwa,Nkonzi Pacific,Georges Assumani Martin,Jean Christian Amini Kabwana,Anuj Kumar,Ali Toloue Ostadgavahi,Mansi Dutt,Kawaya Lusante Bénite,Mangura Hamuli Damien,Christian Gortázar,Bahaa Abu-Raya,Alyson A Kelvin,Kaleme Kiswele Prince,David J Kelvin The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p590 21 Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2×2 factorial, superiority trial 坦桑尼亚和乌干达HIV相关脓毒症的即时或高剂量抗结核治疗（ATLAS）：一项3期、开放标签、随机对照、2×2析因、优效性试验 Scott K Heysell,Stellah G Mpagama,Edwin Nuwagira,Bibie Said,Mark Conaway,Megan Null,Tania A Thomas,David R Boulware,Eva Otoupalova,Rinah Arinaitwe,Rhina Mushagara,Louisa Edwards,Peter Buzaare,Athumani M Ngoma,Davis Muganzi,Geofrey Gidoi,Samuel Jjunju,Antony Gulinja,Arestaricky G Rimoy,Fredrick C Mwita,Jeremiah Kidola,Oscar Atwiine,David Ocaaki,Dalton K Munyambalu,Jie Liu,Lucas Ampaire,Buliga Mujaga,Prakruti Rao,Alphonce Liyoyo,Margaretha Sariko,Conrad Muzoora,Christopher C Moore The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p601 22 Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial 7天高剂量伯氨喹和单剂量他芬诺奎与14天低剂量伯氨喹治疗间日疟原虫疟疾的有效性和安全性（EFFORT）：一项多中心、开放标签、随机对照、优效性试验 Tamiru Shibiru Degaga,Ayodhia Pitaloka Pasaribu,Rupam Tripura,Najia Ghanchi,Megha Rajasekhar,Bipin Adhikari,Benedikt Ley,Samuel Alemu Bamboro,Fareeha Abdul Jabbar,Nurfadhilah Hasibuan,Tedla Teferi Tego,Shane Zehra,Bushra Qurashi,Hellen Mnjala,Grant Lee,Peixuan Li,Abdul Momin Kazi,Widaya Safitri,Yulita Yulita,Dedi Sahat Parningotan Siagian,Deni Syahputra,Halik Hadi,Taj Muhammad,Amna Ibrahim,Nasreen Syed,Khuda Dost,Agatha Mia Puspitrasari,Pinkan Pertiwi Kariodimedjo,Anjana Rai,Angela Rumaseb,Edwin Sutanto,Mom Ean,Asia Khan,Meas Sokha,Robert James Commons,Sophie Weston,Rintis Noviyanti,Tom Peto,James J Callery,Umair Ali,Tariq Mehmood,Arjen Dondorp,Angela Devine,Ery Setiawan,Muthoni Mwaura,Sarah Cassidy-Seyoum,Rodas Temesgen,Dagimawie Tadesse Abate,Eyerusalem Beyene Erjabo,Geremew Gashaw Gessa,Fitsum Getahun Kiros,Muhammad Imran Usmani,Ali Raza,Adugna Woyessa,Asrat Hailu,Julie A Simpson,Amalia Karahalios,Mohammad Asim Beg,Lorenz von Seidlein,Lek Dysoley,Sarah Auburn,Ric N Price,Kamala Thriemer The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p614 23 Efficacy of ETVAX, a vaccine against enterotoxigenic Escherichia coli-positive diarrhoea in Gambian children: a double-blind, randomised, placebo-controlled, phase 2b trial ETVAX疫苗对冈比亚儿童产肠毒素大肠杆菌阳性腹泻的有效性：一项双盲、随机、安慰剂对照、2b期试验 M Jahangir Hossain,Fatou Secka,Lady C Sanyang,Raifu Taiwo,Emmanuel C Okoh,Olubunmi A Olubiyi,Mbemba Drammeh,Emmanuel U Richard,Ahmed D Balami,Mama Drammeh,Samba Juma Jallow,Bakary Sonko,Paticia Ezedimbu-Michael,Jacinta Obiaduo,Ousman Secka,Joanna Kaim,Björn Sjöstrand,Agneta Lissmats,Nils Carlin,Umberto D'Alessandro,Ann-Mari Svennerholm,Thomas F Wierzba The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p627 24 Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trial 伤寒和副伤寒A沙门氏菌结合疫苗候选物在欧洲健康成人中的安全性和免疫原性：1期随机对照试验 Ilse De Coster,Mohammad AbdelGhany,Eleanna Sarakinou,Chiara Fineschi,Elisa Marchetti,Rita La Gaetana,Simona Nigro,Martina Carducci,Luisa Massai,Valentino Conti,Omar Rossi,Giulia Luna Cilio,Alimamy Serry-Bangura,Pietro Tessitore,Pierre Van Damme,Kanchanamala Withanage,Francesca Micoli,Francesco Berlanda Scorza,Simona Rondini,Usman N Nakakana,Ashwani Kumar Arora The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：p638 Review（综述） 25 British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 update 英国医学真菌学会严重真菌病诊断最佳实践建议：2025年更新 Silke Schelenz,Alireza Abdolrasouli,Darius Armstrong-James,H Ruth Ashbee,Richard Barton,Tihana Bicanic,Andy Borman,Lottie Brown,Chris Eades,Laura Ferreras-Antolin,Rebecca Gorton,Ronan McMullan,Iain Page,Nelun Perera,Riina Rautemaa-Richardson,Johannes Wagener,P Lewis White,David W Denning The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e217 26 Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia 血液系统恶性肿瘤或造血干细胞移植后发热性中性粒细胞减少患者的经验性和目标性抗菌治疗：第10届欧洲白血病感染会议建议 Dina Averbuch,Yuri Vanbiervliet,Francesco Baccelli,Malgorzata Mikulska,Dionysios Neofytos,Carolina Garcia-Vidal,Manuela Aguilar-Guisado,Nicole Blijlevens,Patricia Munoz,Catherine Cordonnier,Murat Akova,Thierry Calandra The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e232 Personal View（个人观点） 27 Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development 结核病治疗的未来保障：药物与耐药性检测协同开发框架 Francesca Saluzzo,Seda Yerlikaya,Susan Elizabeth Dorman,Kathleen Eisenach,Maha Reda Farhat,Nazir Ismail,Christian Lienhardt,Timothy M Walker,Fatima Jones,Ana Yepes,Adam Penn-Nicholson,Morten Ruhwald,Bavesh Kana,Claudia Maria Denkinger,Daniela Maria Cirillo The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e248 Grand Round（大查房） 28 Below-knee amputation following osteomyelitis from multidrug-resistant Stenotrophomonas maltophilia in a diabetic foot ulcer 糖尿病足溃疡中多重耐药嗜麦芽窄食单胞菌骨髓炎致膝下截肢 Alejandro Arbona-Lampaya,Ricardo A Pérez-Ojeda,Melanie Santos-Marrero,Adrián Pérez-Aybar The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e257 Clinical Picture（临床图像） 29 Severe inguinal bubo and haemorrhagic exanthem in autochthonous clade Ib mpox 本土伊布分支猴痘导致的严重腹股沟淋巴结肿大和出血性皮疹 Patrick E Obermeier,Philipp Schulz,Hartmut Stocker,Ingo Ochlast,Livia Schrick,Annika Brinkmann,Pascal Migaud The Lancet Infectious Diseases. Jun 2026，Vol 26(6)：e266